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Resumo 
Linfócitos e o seu desenvolvimento têm sido extremamente estudados nos últimos 
anos. A família de linfócitos inclui células T, células NK (Natural Killer) e a nova família de 
ILCs (Innate Lymphoid Cells). 
O processo de desenvolvimento de células T a partir de células progenitoras tem sido 
estudado ao largo de vários anos e é um processo relativamente bem caracterizado: 
precursores saem da medula óssea ou do fígado fetal, durante o desenvolvimento 
embrionário, e chegam ao timo como progenitores de células T. Ao longo do 
desenvolvimento dentro do timo, timócitos imaturos vão adquirindo a expressão de 
co-receptores e receptores característicos de células maduras, tais como CD3 e TCR (T cell 
receptor). Ainda que esta seja a rota tomada pela maioria das células T, outros 
mecanismos geracionais parecem existir tanto a priori da migração para o timo, no feto, 
como independentemente do timo, pós nascimento. Exemplo desta via alternativa é o 
facto de ratinhos sem timo apresentarem células T nas suas mucosas. 
Mesmo dentro das populações de células T que são geradas no timo durante o 
desenvolvimento embrionário, algumas subpopulações parecem ser capazes de se 
manterem independemente do timo no adulto, sendo a pele de particular interesse. 
DETCs (Dendritic epidermal T cells) são células T caracterizadas pela expressão de 
Thy1 (thymocyte antigen 1) e um TCR único, Vγ3Vδ1. Estas são as primeiras células a 
expressarem um TCR no timo fetal e após expressão de CD3 e do TCR maduro esta 
população expande e migra para a epiderme. Neste tecido, DETCs participam em 
processos de cicatrização, vigilância imunitária, entre outros. Estudos mostraram que esta 
população celular tem a capacidade de se renovar independentemente de precursores 
que circulam no sangue, nomeadamente aquando exposição a radiação. Contudo, o 
mecanismo exacto pela qual esta renovação ocorre é ainda desconhecido e a questão da 
existência de progenitores de DETCs na epiderme mantém-se sem resposta. 
No laboratório, usando uma combinação de modelos animais imuno-suficientes ou 
deficientes introduzimos uma nova camada no compartimento linfóide da epiderme. 
Neste trabalho revelámos a descoberta de uma nova população de linfócitos que aparece 
na epiderme durante fases tardias do desenvolvimento embrionário e decresce após 
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nascimento em animais wild type (WT). No entanto, verificámos que esta mesma 
população de células acumula na epiderme de animais com defeitos intrínsecos ou 
extrínsecos na geração de células T, tais como ratinhos deficientes em Rag ou atímicos. A 
esta população de células chamámos ELC (Epidermal Lymphoid Cells).  
As ELCs apresentam à sua superfície moléculas características de linfócitos, como 
Thy1 e CD2, contudo não possuem expressão de moléculas características de células T 
maduras, tais como CD3 ou receptores de células T (TCR) αβ/γδ, sendo este fenótipo 
característico de progenitores de células T. 
De forma semelhante às DETCs, as ELCs mostram ser resistentes a radiação e 
capazes de se autorrenovarem in situ, impondo como possibilidade esta população 
colonizar a epiderme antes do nascimento. Contudo, ELCs encontradas na epiderme de 
ratinhos adultos ou na epiderme neonatal apresentam níveis equivalentes de expressão 
de pre-TCRα (pTα) mas variam nos seus níveis de expressão de CD3 no citoplasma. Tais 
características estão em concordância com a hipótese preliminar desta população ser um 
conjunto de progenitores de células T, possivelmente em diferentes fases de 
desenvolvimento. No entanto, após ensaios de diferenciação in vivo, in vitro ou ex vivo, as 
ELCs mostraram não ter capacidade de se diferenciarem em células T maduras, ou de 
progredir no processo de desenvolvimento de progenitores do mesmo tipo celular. Este 
conjunto de resultados repudiou a hipótese de ELCs serem progenitores de células T. 
Uma vez que o antigénio Thy1 não é específico de linfócitos T, sendo também 
partilhado pela linhagem de células NK, pôs-se a hipótese das ELCs pertencerem à família 
de células NK. Curiosamente, estas células mostraram ser dependentes de vias de 
sinalização ligadas a IL-15 e à cadeia gama comum (γc). É de notar que todos os linfócitos 
são dependentes de sinalização através de γc e que a interleucina IL-15 tem sido 
altamente associada ao desenvolvimento e manutenção de células NK. Ademais, ao 
explorar a expressão de moléculas únicas desta família celular, observámos que as ELCs 
expressam moléculas como NK1.1, CD49b e CD244 na sua superfície.  
Relevante para a caracterização de uma população é o seu perfil de produção de 
citocinas e de dependência de factores de transcrição. Perante condições estimulatórias 
as ELCs mostraram-se produtoras de IFN-γ e IL-2. Além disso, análises de animais 
deficientes para Runx3 e Nfil3, factores de transcrição cruciais para desenvolvimento de 
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células NK, mostraram um decréscimo significativo na frequência de ELCs nas suas 
epidermes. Este conjunto de resultados fortalece a possibilidade de ELCs pertencerem à 
família de células NK. 
Em suma este trabalho aponta para a descoberta de uma nova população de 
linfócitos na epiderme de ratinhos, que devido à fase do desenvolvimento em que são 
encontrados, poderão interagir com outros componentes celulares e participar em 
mecanismos tolerogénicos aquando colonização da pele pelo seu microbioma. Contudo, 
mais estudos terão de ser realizados de forma a compreender a verdadeira natureza, 
origem e função desta população. 
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Abstract 
T cell progenitors are known to migrate from the fetal liver in embryos and the bone 
marrow in adults to the thymus where they differentiate into naïve T cells and then 
egress to peripheral tissues. However, different studies have shown that a pool of T cell 
progenitors may also exist in the periphery. Here, we identify a lymphoid population 
resembling these progenitors which transiently seed the epidermis during late 
embryogenesis in both WT and T cell-deficient mice, which we named ELCs (Epidermal 
Lymphoid Cells). These Thy1+CD2+ cells lack expression of CD3 and TCRαβ/γδ at their 
surface, reminiscent of the phenotype of extra or intra-thymic T cell progenitors, as well 
as Natural Killer cells. Similarly to dendritic epidermal T cells (DETC), ELCs are radio-
resistant and capable of self-renewal, suggesting that the pool of ELCs that seed the skin 
during embryogenesis maintains itself throughout life. Additionally, ELCs have partial 
expression of T cell lineage markers, such as CD3 in their cytoplasm and expression of 
pTα. However, when introduced to in vitro, ex vivo and in vivo differentiation assays, ELCs 
did not differentiate into conventional T cells or DETCs, conclusively showing that they are 
not T cell progenitors. Nonetheless, upon phenotype analysis ELCs revealed to be 
IL15-dependent, express NK-lineage markers such as NK1.1, CD49b and CD244 and 
produce IFN-γ and IL-2 under stimulatory conditions. On top of that, ELCs have also 
shown to be dependent on the transcription factors Runx3 and Nfil3. Altogether, we 
report the discovery of a unique population of lymphoid cells within the murine epidermis 
with characteristics that point towards ELCs being a pool of NK-like cells. Whether ELCs 
interact with other immune or non-immune cell populations leading to unique immune 
functions in the epidermis remains to be investigated. Moreover, further studies would 
have to be addressed in order to further characterize the true origin, nature and function 
of such a population. 
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1. Introduction 
1.1 Skin as an Immune Organ 
As the largest organ of the body, the skin functions as a physical barrier preventing 
the entry of foreign pathogens; however, at the same time it also provides a home to 
numerous commensals. The interface between skin microbiota and its derived 
immunological responses requires a very delicate balance between host and 
microorganism1–3. In mammals, the skin is composed of the epidermis, attached to a 
basement membrane, underlain by the dermis and a subcutaneous fatty region. The 
resident cell populations that make up these strata can be broadly divided into immune 
and non-immune cells. The epidermis is comprised primarily of keratinocytes which are 
tightly connected to one another forming an outer enucleated, cornified layer referred as 
the stratum corneum. This “brick wall” ensures an effective physical barrier limiting the 
access to the internal environment4,5. The immune pool of the epidermis includes 
Langerhans cells (LC), Dendritic Epidermal T cells (DETC, restricted to the murine 
epidermis) and Tissue-resident Memory T cells (TRM) (Figure 1). Of note that TRM colonize 
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Figure 1.  Representative scheme of the skin structure and immune cell types found in the skin.  
Skin is composed of epidermis and dermis forming two cellular environments separated by a basement 
membrane. Multiple immune cell types are found within the skin, including Langerhans cells, Dendritic 
Epidermal γδ T cells and memory αβ T cells in the epidermis. In steady state, the dermis contains a 
heterogeneous mix of immune cells, including subsets of dendritic cells, macrophages, neutrophils, mast 
cells, Innate Lymphoid Cells and T cells. Blood and lymphatic vessels and nerves (not shown) are also 




The epidermis and dermis are physically separated by a thin base-membrane of 
extracellular matrix proteins that regulates cell movement across. The dermis is primarily 
comprised of extracellular matrix proteins that give the skin its structure and elasticity. 
Unlike the epidermis, the dermis allows a less restrained migration of cell populations and 
has a much more complex cellular constitution. Numerous immune populations can be 
found in the dermis including dermal Dendritic Cells (DDC), Macrophages, Neutrophils, 
Mast cells, Innate Lymphoid Cells (ILCs) plus different subsets of T cells (Figure 1) 1,7–9. 
 
1.1.1 Organogenesis 
The embryonic epidermis is covered by a transient protective layer of tightly 
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age (E) 9-12, out of the 20 days of mouse development, and between 4-7 weeks out of 
the 40 week gestational age (EGA) in humans the periderm appears10–12. The periderm 
first emerges as a simple layer derived from basal keratinocytes, undergoes a series of 
changes which alter both the surface morphology and the subcellular organization, and 
then disappears when epidermal keratinization is complete11. The function of the 
periderm is not well described, but may be related to transport/exchange between the 
fetus and the amniotic fluid. The epidermis loses its periderm while acquiring the stratum 
corneum, which occurs around E16.5–E17.5 in mice and between 15 and 22 week EGA in 
humans10,11. Just below the epidermis is the basal lamina, composed of extracellular 
matrix proteins including integrin and laminin, followed by the dermis which derives from 
the mesoderm. The dermis provides mechanical structure via a network of connective 
tissue, which includes the proteins collagen and elastin. Hair follicles, sebaceous glands, 
sensory nerves, and vasculature are within the dermis13.  
 
1.1.2 Other immune sentinels (non-T cells) 
Some examples of immune sentinels that can be found in the epidermis and 
dermis are dendritic cells (DCs), macrophages, mast cells and ILCs. 
Skin DCs can be classified according to their location in distinct anatomical 
compartments of the skin: Langerhans cells are the main DC subset in the epidermis, 
where they constitutively reside in the suprabasal layers and are regularly spaced among 
keratinocytes14; whereas dermal DCs reside in the dermis immediately below the dermal-
epidermal junction. Dermal DCs have been reported to be particularly important for T cell 
responses and viral immunity15,16. Other possible roles are not so clear, though in other 
tissues they have been linked to T Helper (Th) 17 cell–mediated immunity
17,18. 
In the mouse, there are two main DC dermal populations corresponding to the 
CD11b+ DCs and CD103+ DCs19,20. Several studies have reported that CD11b+ DCs can be 
further divided; with one group deriving from pre-DC and the other derived from 
monocytes19,21,22. The murine skin dermal DC panel can be nicely matched with the DCs in 
human dermis, which comprises up to three different subsets: CD1c+ DCs, CD14+ DCs and 
CD141+ DCs subset. Whereas human CD141+ DCs match mouse CD103+ dermal DCs, and 
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human CD1c+ DCs of pre-DC origin and CD14+ DCs of monocyte origin would together 
make up the mouse CD11b+ dermal subset 16,23,24. Langerhans cells (LCs) can be found on 
both mouse and human epidermis and have been distinguished from other cells by the 
expression of langerin and CD1a, respectively16,20. LCs acquire antigens, transport them to 
regional lymph nodes, present them to naїve T cells and initiate adaptive immune 
response25–27. LCs have strong immunogenic properties but they may also act as 
mediators of tolerance, for example to commensal bacteria28–30. They are involved in 
antimicrobial immunity, skin immunosurveillance, induction phase of the contact 
hypersensitivity and in the pathogenesis of chronic inflammatory diseases of the skin31,32.  
While dermal DCs migrate rapidly to lymph nodes, skin macrophages are 
predominantly sessile dermal cells33–35. Dermal macrophages have been reported to have 
antimicrobial activity and to produce pro-and anti-inflammatory mediators36–40. Mast 
cells are the major effector cells of immediate hypersensitivity reactions, which are 
mediated by the release of their granule contents upon antigen-mediated cross-linking of 
Fc-bound IgE on their surface41,42. Similarly to macrophages, mast cells and basophils can 
have pro-inflammatory and anti-inflammatory functions in the skin43,44. Mast cells also 
seem to have a role in the eradication of parasites, during acute bacterial infections and 
maybe even in wound healing, but a protective function of mast cells is still under 
discussion45,46. Innate lymphoid cells are a newly described family of cells that have been 
extensively characterized in the past few years. However, so far only natural killer cells 
(NKs) and ILC type 2 (ILC2) have been detected in healthy skin. NKs  are usually present in 
small numbers that are increased in inflammatory conditions, such as psoriasis47–49. ILC2 
have been reported by Roediger et al where in the steady state, this population has often 
been found to associate with mast cells as they trafficked through the dermis. 
Constitutive production of IL-13 by this ILC2 population has shown to suppress the 
function of mast cells50. However under inflammatory conditions other type of ILCs such 
as ILC type 3 (ILC3) can be found in the skin51.  
 
1.1.3 T cells as immune sentinels 
In humans, healthy skin contains more than 2x1010 skin-resident T cells, which is 
more than twice the total number of T cells in the blood52. The human epidermis harbors 
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a phenotypically heterogeneous population of T cells, most of which are CD8+ αβ T 
cells53,54. These CD8+ T cells usually reside for longer periods without reentering the 
circulation, being therefore commonly referred to as tissue-resident memory T cells 
(TRM)
54,55. Epidermal T cells are mainly distributed in the basal and suprabasal 
keratinocyte layer, often in close proximity with Langerhans cells54. However, in the 
murine epidermis another population of T cells can be found, the Dendritic Epidermal T 
cells (DETC). This unique population of γδ T cells forms a prominent network in the skin in 
mice where they appear to monitor the integrity of the epidermal layer56–58. No exact 
equivalent has been reported in the human so far. 
In the dermis, T cells are preferentially clustered around postcapillary venules and 
are often situated just beneath the dermal-epidermal junction or adjacent to cutaneous 
appendages53. In humans the ratio of CD4+ and CD8+ T cells is generally almost equal and 
most are memory T cells that express cutaneous lymphocyte-associated antigen (CLA), 
while in mouse it is believed that the ratio of CD4+/CD8+ T cells is uneven, as the 
predominant population in the murine dermis would be CD4+ T cells52,53,59. Skin-specific 
memory T cells gain skin-homing properties after a process known as imprinting, which 
involves contact with tissue-derived DCs and possibly mesenchymal cells60,61. Regulatory T 
cells (Tregs) are also found in substantial numbers in healthy dermis, both mouse and 
human, and their contribution to immunity of inflammation appears to be regulated by 
skin commensals62. 
 
1.1.3.1 γδ T cells 
Epithelia exposed to the environment, such as those that line the gastrointestinal, 
reproductive and bronchoalveolar tracts, as well as skin, are under the surveillance of 
resident T cells that express mainly γδ invariant or restricted T cell antigen receptors 
(TCRs). Several studies have reported the variety of γδ T cell in both mouse and human 
skin but not all of them agree. 
As mentioned before, the murine epidermis harbors a very specific type of γδ T 
cell, DETC. These dendritic shaped T cells have been reported for the first time in 1983 by 
Georg Stingl’s team and after that many other studies have been published where 
researchers explore the different characteristics of this unique population. DETCs express 
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a canonical γδ TCR composed of Vγ3/Jγ1-Cγ1 and Vδ1/Dδ2/Jδ2-Cδ chains, and have not 
been found elsewhere in the adult mouse. DETC precursors are the first T cells to develop 
in the embryonic thymus, and remain the predominant CD3+ fetal thymocyte until E17.5, 
coinciding with their migration to the epidermis. DETCs have been reported to work 
closely with keratinocytes in immunosurveillance of the epidermis. Once keratinocyte 
distress is detected, DETCs respond by local secretion of chemokines, cytotoxic effector 
molecules, growth factors and cytokines that orchestrate skin inflammation, tumor killing 
and wound healing responses63–65. While murine epidermal γδ T cells have been 
extensively studied, dermal γδ T cells have been less well described. However in 2011 
Weninger’s team has identified an abundant population of resident dermal γδ T cells. 
These cells can be differentiated from DETCs by the display of a unique phenotypic 
profile, being Vγ4+Vγ3-  or Vγ4-Vγ3-66. Both populations are implicated in the 
immunosurveillance of the skin by being involved in protective immunity against 
mycobacterial infections and by producing IL-17 upon inflammatory conditions66,67. It is 
possible that murine dermal γδ T cells have other functions that remain to be identified.  
On the other hand the majority of T cells in the human skin are far from being γδ T 
cells. Some studies have reported that around 18-29% of the CD3+ cells of the epidermis 
express γδ TCR, while others have contradicted these numbers by reporting that less than 
0.1% of CD3+ intraepidermal lymphocytes express the γδ TCR54,68–70. Characterization of 
these cells and their role in local immune responses awaits further investigation. In the 
dermis, human γδ T cells make up a small portion of the total number of T cells. The TCR 
repertoire of the γδ T cells in the human skin has been described previously as polyclonal, 
however new studies claim that a much more restricted repertoire is actually present and 
that is different from the one found in the peripheral blood or in the skin of the mouse71. 
However in general, further studies will be required to better characterize and elucidate 
the function of γδ T cells in human skin and their involvement in the 
immunopathogenesis of skin diseases. 
 
1.1.3.2 αβ T cells 
Human skin contains a large number of αβ T cells, essentially all of memory 
phenotype. These memory T cells consist of both CD4+ and CD8+ subset, with about 10% 
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of the CD4+ T cells expressing Foxp3, indicative of a Treg cell phenotype
72. Researchers 
have also classified two major types of αβ T cells: tissue-resident memory cells and 
effector-memory cells. The first group is disconnected from blood circulation and remains 
permanently in the tissue, while the second group is in circulation in the blood and just 
passes through the tissue. Human skin resident T cells have been reported to have a 
remarkably diverse TCR repertoire, and most have a phenotype of Th1 effector memory 
cells, although Th2 cells, central memory cells, and functional Tregs are also present
52. 
Carbone’s team was one of the first providing evidence that a population of 
peripheral memory T cells seemed to be in disequilibrium with the circulation in the 
mouse skin. These resident T cells were CD8+ T cells found preferentially in the epidermis 
and were expanded in acute infection models55. CD8+ TRM are derived from the same 
precursor cells that give rise to the long-lived memory cells found in circulation. These 
precursors undergo an in situ developmental program that results in their differentiation 
into specialized, long-lived memory cells adapted to the extralymphoid compartment6. 
Numerous studies have shown that memory T cells in the lung, skin and gut provide 
increased protection during a secondary infection at these sites73–75. Cell migration to the 
skin is marked by segregation of the CD4+ T effector memory cells (TEM)  to the dermis and 
CD8+ TEM cells to the epidermis
76. This migration process involves several molecules, 
where cutaneous effector-memory cells that are programmed to migrate selectively to 
the skin express P- and E-selectin ligands and the chemokine receptors CCR4 and/or 
CCR10. These receptors are critical for T cell homing into the skin which interact with the 
dermal-associated chemokines CC-chemokine ligand 17 (CCL17) and CCL27, respectively. 
Recent reports have shown that non-haematopoietic peripheral tissue cells and lymph 
node-resident stromal cells can also influence the tissue tropism of T cells60,61. TEM cells 
generated as a result of epithelial tissue infections can accumulate as TRM cells at both 
sites of infection as well as at distant sites within the same epithelial tissue, providing 
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1.2 T cell development 
Development of mature T cells is a much studied topic, starting from where the 
progenitors come from before entering the thymus, passing through the different events 
in this organ and ending with the export of mature naïve T cells to the periphery. 




In adult mammals, hematopoiesis normally occurs in the bone marrow (BM), 
which supports simultaneously, within distinct cellular environments, the life-long 
maintenance of stem cells and the regulated production of end-stage lymphoid, myeloid 
and erythroid cells. Hematopoietic stem cells (HSC) found in the adult bone marrow arise 
by replication and amplification of a stock of HSC that emerged early in ontogenesis, 
when the bone marrow had not yet formed. The production of blood stem cells is 
accomplished by the allocation and specification of distinct embryonic cells in a variety of 
sites that change during development. In mammals, the sequential sites of hematopoiesis 
include the yolk sac (YS), an area surrounding the dorsal aorta termed the aorta-gonad 
mesonephros (AGM) region, the fetal liver, and finally the bone marrow. Recently, the 
placenta has been recognized as an additional site that participates in hematopoiesis 
from the AGM to the fetal liver period78–80. After E11.5, the fetal liver serves as the major 
hematopoietic organ generating all hematopoietic lineages81. Subsequent definitive 
hematopoiesis involves colonization of the fetal liver, thymus, spleen, and ultimately the 
bone marrow82. 
 
1.2.2 Thymic education 
While during development T cell progenitors are released from the fetal liver and 
into the blood stream making their way into the thymus, during adulthood progenitors 
are released from the bone marrow instead83,84. Once progenitors reach the thymus, they 
undergo multiple rounds of proliferation and differentiation. This sequence of events 
leads to T cell lineage commitment, TCR rearrangements, and the generation of αβTCR- or 
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γδTCR-expressing T cells that function as killers, regulatory cells or producers of specific 
cytokines83. Only after positive selection and maturation are functional T cells released 
into the periphery or home to the different tissues85. 
Petri’s team has shown that an intricate movement through defined thymic 
regions occurs during thymocyte development. Lymphoid progenitors enter the thymus 
at the cortico–medullary junction, then migrate to the outer cortex, and finally return to 
the medulla by a process that includes several carefully coordinated selection events86–88. 
This complex and probably chemokine-directed89 migration through the thymus has 
helped establish the view that T cell development requires many unique interactions that 
can only be provided in the context of the whole thymus. 
From the time that a lymphoid precursor arrives in the mouse thymus to the first 
expression of an αβTCR, it undergoes multiple phenotypically distinct stages that are 
defined by the expression of CD4, CD8 and other markers. The first stage of thymic 
differentiation is called Double Negative (DN) 1 defined by the phenotype CD25− (alpha 
chain of the IL-2 receptor), CD44+ (Receptor for hyaluronic acid), CD117+ (c-kit, Mast/stem 
cell growth factor receptor), IL-7Rα+ (Interleukin-7 receptor subunit alpha) and CD90+ 
(Thy1, Thymocyte antigen 1) (Figure 2Figure 3). The DN1 subpopulation constitutes a 
heterogeneous mixture of cells, which can be divided into five distinct subsets (DN1a–e) 
based on surface expression of CD117 (c-kit) and CD24 (heat stable antigen)90. Canonical 
T cell progenitors are confined to the CD117high subsets DN1a and DN1b90, which 
correspond to early T lineage progenitors (ETPs), generally considered the earliest intra-
thymic T lineage precursors91–93. Cells progress from DN1 to DN2 by expressing CD25 
(Figure 2Figure 3). At this stage, the first rearrangements start in the β, γ , and δ loci of 
the TCR; a process that is completed in DN3 cells. DN1 and DN2 thymocytes retain the 
capacity to differentiate to NK, although a few B and myeloid precursors have been 
detected94,95. Cells then continue to the DN3 stage when they lose expression of CD44 
and CD117. The DN3 stage is a mandatory checkpoint at which expression of the pre-TCR 
or the γδ TCR results in signals that rescue cells from apoptosis and lead to thymocyte 
proliferation and further differentiation (Figure 2Figure 3). Cells that fail to express a TCR 
at this stage undergo apoptosis before the transition to DN4 (CD25−)96.  
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Figure 2. Early stages of T cell development. 
The initial stage of T cell progenitor found in the thymus is named double-negative 1 (DN1)–early thymic 
progenitor (ETP). Upon CD25 expression DN1 transit into DN2, the stage where T cell lineage specification 
occurs. After the loss of CD44 expression cells become DN3, and the T cell lineage commitment occurs, 
meaning these progenitors no longer have the ability to differentiate into other cell lineages other than T 
cell. Followed by the pre-TCR signalling DN3 become DN4 (CD25
-
), being then ready for a full maturation of 
the TCR into the next steps of T cell development. 
 
Expression of rearranged TCRβ and formation of the pre-TCR complex leads to a 
series of events collectively known as β-selection, resulting in allelic exclusion of the TCRβ 
locus, expansion and differentiation to the double-positive (DP) stage, or γδ selection97. 
As an intermediate stage after the DN stages, thymocytes express CD8 and become 
immature single-positive (ISP) CD8+ thymocytes before expressing CD4 and becoming 
CD4+CD8+ DP thymocytes98. 
During development it takes a little more than a day for the first wave of lymphoid 
precursors that populate the fetal mouse thymus to generate DN2 cells (this occurs from 
E12.5 to E14) and only a total of four days for the first DP cells to appear (at E16). By 
contrast, the lymphoid precursors that continuously enter the thymus throughout young 
adult life can take ten days to reach the DN2 stage and two weeks to develop into DP 
cells, with the extra time providing the opportunity for much more extensive 
proliferation88,99. 
Thereafter, αβ T lineage cells downregulate CD25 and upregulate CD4 and CD8 to 
generate DP cells that constitute the majority of thymocytes (~80%). DP cells undergo 
TCRα gene rearrangement and the resulting αβ TCR heterodimer then undergoes Major 
Histocompatibility Complex (MHC)-mediated selection to yield mature CD4 or CD8 single-
positive (SP) T cells. Conversely, most of the γδ T lineage cells remain DN cells but 
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to reside in medullary areas for up to two weeks, a time during which they undergo 
changes in expression of a variety of cell-surface molecules, such as CD24, CD62L, CD69, 
among others, before they are exported to the periphery100,101. Interactions between 
Notch receptor-expressing thymocytes102 and thymic stromal cells that express Notch 
ligands103,104 are also implicated in the complex program of T cell maturation. Ultimately, 
these interactions result in the generation of self-tolerant CD4+ helper T cells and CD8+ 
cytotoxic T cells, which emigrate from the thymus to establish the peripheral T cell pool. 
Interestingly, in addition to the much studied thoracic thymus, a second thymus 
has been reported in adult mice in the cervical area105,106. These cervical lymphoid 
structures displayed a medulla-cortex architecture, as well as the presence of DP and 
both CD4+ or CD8+ SP thymocytes with expected levels of TCR/CD3 expression. The 
cervical thymus appears to support a functional thymocyte development, including 
selection and export of T cells with diverse TCR repertoire into the periphery. These 
second thymi appear to arise postnatally, however their anatomic position and number of 
structures show a degree of variability105,106. The actual contribution to the overall T cell 
pool in the mouse is yet to be clarified. Nevertheless, cervical thymus tissue has been 
observed in other species, including humans107. During embryogenesis, in human fetus, 
the existence of cervical thymus seems to be quite frequent108,109; however their 
prevalence after birth is usually associated with pathological conditions110–112. 
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Figure 3. T cell development in the thymus.  
The thymus is a lobulated organ divided by mesenchymal septae. Lobes are organized into discrete cortical 
and medullary areas, each of which is characterized by the presence of particular stromal cell types, as well 
as thymocyte precursors at defined maturational stages. Thymocyte differentiation can be followed 
phenotypically by the expression of cell-surface markers, including CD4, CD8, CD44, CD25, CD69 and CD62L, 
as well as the status of the T cell receptor (TCR). Interactions between thymocytes and thymic stromal cells 
are known to be important in driving complex programmed T cell maturation in the thymus, which 
ultimately results in the generation of self-tolerant CD4
+
 helper and CD8
+
 cytotoxic T cells. Mature T cells 
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1.2.3 Extrathymic education 
Even though thymic development of T cells has been intensely studied in the past 
years it is still a very controversial field. Several studies have been published showing that 
extrathymic education of T cells can occur especially since athymic (nude) mice have T 
cells. This extrathymic lymphopoiesis, however, has special features. It populates mainly 
the gut mucosa leading to the accumulation of T intraepithelial lymphocytes (IELs). Also in 
normal euthymic mice, a fraction of T cells do not follow the rules of repertoire selection 
dictated in the thymus. These cells do not differentiate through the CD4+CD8+αβ+ 
thymocyte pathway. 
 
1.2.3.1 T cell development in the gut and mesenteric lymph nodes 
In wild type mice, the intestinal epithelium harbors different TCR-positive 
lymphocytes functioning as the first line of defense against enteric pathogens. T-IELs are 
abundant and consist of γδ+ T cells (30–40%) and αβ+ T cells, not only CD4+ or CD8αβ+ but 
also CD8αα+, which are a variety of αβ+ T cells clearly identified only in the gut 
epithelium114. The TCR expression of this last population has a special recognition pattern 
directed mainly toward MHC I–like antigens115–117 and also contains superantigen-reactive 
TCRβ chains118, suggesting that these cells have not been submitted to negative selection. 
The likelihood that agonist-selected DP cells may produce a fraction of the CD8αα T-IELs 
present in normal mice remains to be discussed. CD8αα T-IELs are generated normally in 
conditions where agonist selection in the thymus is impossible, as in CD3-ζ-deficient 
mice119. Their CD8β chain remains methylated, in contrast to DP cells, and mature CD4+ or 
CD8αβ+ cells are present in the periphery or in the gut, indicating that CD8αα T-IELs never 
went through a DP stage120. Finally, the location of DP cells deep in the thymic cortex 
does not allow them access to efferent capillaries or lymphatics, meaning that DP 
migration to the periphery is very unlikely to happen121. Since they do not appear to 
belong to the DP main thymic pathway, several research groups called them “thymus-
independent”. Nonetheless, experiments with grafts of fetal or neonatal thymus have 
suggested that at least part of these cells might be of thymic origin122,123. All of these 
observations point towards T-IEL from wild type mice to have a dual thymic and 
extrathymic origin. It has been proposed that gut cryptopatches, small aggregates of 
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mucosal lymphocytes at close contact of the epithelium124, are the extrathymic source of 
lymphopoiesis contributing to γδ and αβ T IEL in euthymic or athymic mice125–127. 
However, Vassalli’s team has reported that extrathymic lymphopoiesis is a minor pathway 
of T cell differentiation, taking place mostly in the mesenteric lymph nodes and operative 
only in conditions of defective thymopoiesis but with comparable ontogenic steps128. 
 
1.2.3.2  Extrathymic T-lineage commitment 
The generation of the majority of mature T cells depends on the differentiation of 
T cell progenitors in the thymus84. To ensure this T cell generation, thymus colonization 
by hematopoietic progenitors is essential. However, it is still highly controversial which 
progenitors colonize the thymus and where commitment to T cell lineage differentiation 
occurs. Commitment to lymphocyte differentiation has been associated with the 
generation of common lymphoid progenitors (CLP) in the bone marrow129, however 
several studies have investigated T cell commitment outside bone marrow, before and 
after birth. 
More than twenty years ago Rodewald’s team identified a pro-thymocyte in the 
murine fetal blood, showing that T lineage commitment can precede the thymus 
development. By in vivo transfer  these cells could reconstitute the αβ T cell lineage130. A 
few years later Strober and collaborators showed that a microenvironment within the BM 
is capable of supporting CD4+ and CD8+ αβ T cell maturation from precursors, similarly to 
the thymus131. In addition, Dejbakhsh-Jones and collaborators revealed that an early T cell 
progenitor could be found in the bone marrow. Through a coculture with T cell depleted 
BM, they showed that these cells recapitulated the main reported elements of 
intrathymic T cell maturation, including acquisition of CD2, downregulation of CD16 and 
CD44, before the appearance of αβ TCR on the intermediary CD4+CD8+ DP T cells132. The 
same team named  Rodewald’s cells as Committed T cell Progenitors (CTP)133 and their 
recently described bone marrow population as Committed Intermediate Progenitor (CIP), 
with the second being a possible maturation stage of the first134. Furthermore, Krueger 
and von Boehmer identified a T lineage-committed progenitor in the adult mouse blood 
that when cultured in OP9-DL1 stromal cells, or upon transfer into Rag2-/-Il2rg-/-, 
generated T lineage cells. They were called Circulating T cell progenitors (also CTP)135. 
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In addition to these circulating or BM resident T lineage committed progenitors, 
others have been reported. Katsura and collaborators have shown that the fetal liver 
contains progenitors that are selectively potentiated to differentiate into T lineage cells. 
These were also shown to be distinct from those in the BM, having the ability to generate 
T but not B or myeloid cells in a much shorter period than BM progenitors136,137. 
Moreover, abundant extrathymic T cell progenitors have been found in athymic 
mice and following bone marrow transplantation of irradiated mice, possibly as a result of 
lymphopenia. In addition, upon radiation, major T cell progenitor activity has been 
reported in bone marrow-derived spleen colonies138. Later, the same team provided 
evidence that this population of progenitors represents a unique population, which is 
thymus independent and much more efficient at inducing peripheral T cell reconstitution 
than previously described precursors139.  
Notch signalling has been shown to be active in the extrathymic 
T lineage-committed progenitors and required for their generation140. However, these 
same progenitors have also been detected in the spleens of unmanipulated wild type 
mice, indicating that extrathymic T cell commitment can occur under physiologic 
conditions141. The developmental fate of these extrathymic T cell progenitors is not clear.  
The origins of extrathymic T progenitors and their relationship to intrathymic 
progenitors remain to be defined by future studies. 
 
1.3 Natural Killer and Innate Lymphoid Cells 
Innate lymphoid cells (ILCs) are emerging as important effectors of innate immunity 
and have a central role in tissue remodelling142,143. ILCs are defined by three main 
features: the absence of recombination-activating gene (Rag)-dependent rearranged 
antigen receptors; a lack of myeloid cell phenotypical markers; and their lymphoid 
morphology144. The “founding” members of the ILC family are natural killer (NK) cells and 
lymphoid tissue-inducer (LTi) cells. NK cells mediate early immune responses against 
viruses and are involved in cytotoxicity while LTi cells are essential for the formation of 
secondary lymphoid organs during embryogenesis and for postnatal formation of 
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intestinal lymphoid clusters145–148. These cell types were discovered in 1975149 and 
1997147, respectively, and have been extensively studied throughout the years.  
Recently, several distinct ILC populations have been identified that, similarly to NK 
cells and LTi cells, depend on common gamma chain (γc) and inhibitor of DNA-binding 2 
(ID2) for their development150–152. These ILC populations also rely on signalling through 
interleukin-7 receptor subunit-α (IL-7Rα) for their development and maintenance. Based 
on similarities in effector cytokine secretion and developmental requirements, the ILC 
family can be further divided into type 1, 2 and 3. ILCs are potent innate cytokine 
producers that respond to changes in the cytokine microenvironment, with demonstrated 
roles in early infection control, adaptive immune regulation, lymphoid tissue 
development, and in tissue homeostasis and repair143,153,154. 
 
1.3.1 Ontogeny 
Given that ILCs and adaptive immune system lymphocytes all derive from the 
common lymphoid progenitor (CLP); the question of whether an ILC lineage-restricted 
progenitor for some or all ILC populations exists remains unanswered. 
Within the bone marrow, the CLP gives rise to all ILC lineages, including B and T 
cells142. The earliest progenitor with restricted lineage potential to all ILCs has recently 
been identified as the CXCR6+ αLP (α4β7 expressing CLP; also known as the common 
innate lymphoid progenitor - CILP) (Figure 4)155. The CILP shows multi-lineage 
differentiation, including NK, ILC1, ILC2, and all ILC3 in both in vitro and upon 
transplantation in vivo. This progenitor is dependent on Nfil3; consistent with reports 
showing that Nfil3-/- lack all ILC lineages156,157. However, group 1 ILC subsets in the salivary 
glands, uterus, and possibly liver appear to develop independently of Nfil3. Therefore, the 
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Figure 4. Proposed ILC developmental tree. 
All lymphoid lineages are the progeny of the CLP. After the branchpoint with B and T lineages, the existence 
of an ILC-restricted progenitor (CILP) has been proposed. Downstream two main ILC lineages can be 
discriminated: killer ILCs and helper-like ILCs. CHILP is the common helper-like innate lymphoid progenitor, 
where the ability to give rise to EOMES
+
 NK populations has been lost. Killer ILCs are represented by cNK 
cells and helper-like ILCs are composed of the various cytokine-producing ILC subsets (i.e., ILC1, ILC2 and 




 CHILP. This population then  
bifurcates into RORγt
hi
 LTi precursors (LTiP) and PLZF
hi
 ILCP, the latter of which gives rise to all ILC lineages. 
NK lineage also has its own skewed progenitors. Transition from CILP to NKP involves a sequential 
downregulation of CD135, upregulation of CD122, followed by a downregulation of CD127. A sequential 
population can also be identified as immature NK, where they already express NK1.1 but not CD49b. 
Acquisition of CD49b is linked to NK maturation.  Mature ILC lineages can also be further grouped based on 
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Klose et al, by taking advantage of a reporter mouse for the transcription factor 
Id2, identified a new population of progenitors Id2+Lin-IL-7Rα+α4β7
+CD25-PLZF+/-. These 
cells were named common helper-like innate lymphoid progenitor (CHILP), and identified 
as the next step in the pathway of ILC development after the CILP stage (Figure 4). Upon 
in vivo transfer, CHILP gave rise to EOMES- ILC1, ILC2, NKP46+ ILC3 and NKP46- ILC3, 
including the LTi subset, but not EOMES+ NK cells (Figure 4)159. Although the CHILP was 
identified by Id2 expression, the importance of this transcription factor may not be 
limited to this population, as the KO model lacks NK cells and all three ILC groups150,152. 
Nevertheless, the CHILP population consisted of a PLZF+ and a PLZF- subset, and since 
PLZF is an Id2-controlled gene, this suggests that the PLZF+ subset may be the progeny of 
PLZF- CHILP160.  
On the other hand and even though progenitors expressed PLZF, Constantinides 
and collaborators found that ILCs do not express this transcription factor. However, 
lineage tracing of the expression pattern of Zbtb16, the gene encoding PLZF, revealed that 
all helper-like ILCs were prominently labeled, while conventional NKs (cNK) and LTi were 
not.  As a result, a rare subset of PLZFhiLin-IL-7Rα+α4β7hickit+CXCR6- cells was identified in 
the fetal liver and adult bone marrow. This subset arose as a precursor of ILCs called 
innate lymphoid cell progenitor (ILCP) (Figure 4). In vivo transfer of ILCPs in competition 
with CLPs showed that the first gave rise to greater frequencies of ILCs, confirming them 
to be a progenitor skewed towards ILC lineage. ILCPs efficiently generated ILC1, ILC2 and 
ILC3 but were poor at generating NK cells or LTi158. Therefore it is believed that this 
population is downstream of CHILP (Figure 4). Mice deficient for PLZF have some defects 
in ILC1 and ILC2, suggesting that it might not be essential for all lineages. On top of that, 
PLZFhi population has also been described to co-express high amounts of GATA-3, 
suggesting a link between GATA-3 expression in these ILC precursors and their cell fate 
potential158. Interestingly CLP are negative for GATA-3161 , leading to the theory that 
GATA-3 upregulation in CLPs might be involved in the restriction of B lineage fate and 
thereby generation of T cell and ILC precursors. Such ‘‘bipotent’’ precursors would then 
further differentiate into more restricted T cell lineage precursors or ILC precursors, 
where upregulation of Id2 would be a dominant factor in promoting the development of 
the latter. This model is consistent with the existing data and would clearly distinguish the 
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developmental pathway of conventional NK cells and LTi (GATA-3 independent) from 
other ILC subsets (GATA-3 dependent)162. 
Transition from CLP to NK progenitor (NKP) involves a sequential downregulation 
of CD135, upregulation of CD122, followed by a downregulation of CD127163–165.  In 
addition, Id2 expression also helped identifying an early NK cell restricted progenitor, the 
pre-pro NK. The pre-pro NKs are a transient stage between CLP and NKP where they are 
CD135-CD127+ but negative for CD122166. Interestingly, these pre-pro NK cells also appear 
to phenotypically overlap with an ILC2 precursor population that expresses CD25 and 
T1/ST2166,167. Whether the pre-pro NK population harbors ILC2 potential or whether the 
described ILC2 precursor contains NK cell potential has not been studied. Potentially, 
these populations might represent an interface between ILC1 and ILC2 development. 
Immature NKs (iNKs) are the next step in the development pathway of this specific branch 
of the ILC family (Figure 4). iNK cells can be identified as 
CD3-CD122+NK1.1+CD49b-CD11bhighCD27low and are thought to represent a transient 
developmental intermediate that can further differentiate giving rise to mature NK cells 
(NK1.1+CD49b+CD11blowCD27high) that circulate in the blood and are detected throughout 
the body150,168. It is worth mentioning that the complex process of NK lineage 
differentiation can occur at several distinct tissue sites, including bone marrow, liver, 
thymus, spleen and lymph nodes, and may involve the circulation of NK cells at different 
stages of maturation between tissue169 
The T-box transcription factors T-bet and Eomes have important roles in NK cell 
development. Mice deficient in either of these T-box transcription factors show 
substantially impaired NK cell numbers and diminished function of splenic NK cells, which 
is further aggravated by the combined deficiency of the two factors170,171. Interestingly, 
the transcription factor expression of Eomes in immature NK cells coincides with the 
appearance of CD49b+ (i.e. mature) NK cells. Eomes seems to be specifically required for 
this maturation step in the bone marrow as conditional Eomes-deficient mice have a 
developmental arrest at the CD49b- stage. Consequently, these mice virtually lack all 
CD49b+ NK cells in spleen, liver and lymph nodes and harbour only low numbers of 
immature NK cells in the periphery171. 
Recent work has demonstrated that other IFN-γ-producing NK1.1+ cells are 
present in mucosal sites in humans172 and in mice159,173. These ILC1 subsets require the 
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transcription factors T-bet, Nfil3, and GATA-3 for their generation and are phenotypically 
distinct from conventional NKs. The molecular mechanism through which GATA-3 
contributes to ILC1 development or whether its maintained expression is needed for 
functional attributes is unclear. 
GATA-3 transcriptional activity is a major determinant of ILC2 cell fate in 
uncommitted lymphoid precursors. The transition from CLP to ILC2 is associated with 
upregulation of Id2 and RORα, both of which are essential for ILC2 differentiation167,174. 
ILC3s are the most complex group of ILCs, all of which strictly depend on the 
transcription factor RORγt175. More recently, GATA-3 was shown to be crucial for 
development of both LTi cells and T-bet+ ILC3176,177. ILC3s express abundant GATA-3 
protein, albeit in lower amounts than observed in mature ILC2s176,177. Moreover, in the 
fetus, GATA-3 is critical for differentiation of CD135+α4β7
+ CLP-like cells and cell-intrinsic 
GATA-3 expression is essential to generate fetal liver RORγthiIL-7Rαhi precursor cells 
(LTiPs) (Figure 4)176. LTi, which are closely related to RORγt+ ILC3, derive from α4β7
+ 
precursors, while the other ILC3 derive from α4β7
- precursors that express low levels of 
RORγt175. Interestingly, Id2 is required for the generation of α4β7
+ precursors, but not for 
the generation of α4β7
-RORγtlow precursors, demonstrating that α4β7
+ precursors of LTi 
cells do not generate the precursors of the other ILC3. Nevertheless, all ILC3 fail to 
develop in Id2-deficient mice152,178. Another study has potentially identified LTiP as a 
distinct population consisting of RORγthighPLZF- cells, which was more abundant in the 
fetal liver, and co-expressed high levels of TOX but not GATA3158. Cherrier et al have 
shown that Notch signaling and Id2 are sequentially engaged to generate α4β7
+ precursors 
and that Notch signaling must then be terminated to up-regulate RORγt and generate LTi 
cells179. 
 
1.3.2 Phenotype, localization and function of ILC and cNK 
Mature ILCs have been extensively studied in both mouse and human in terms of 
surface marker expression, tissue localization and function. ILCs can also readily respond 
to a vast array of cytokines such as IL-1, IL-12, IL-7, IL-23, IL-25, IL-33 and thymic stromal 
lymphopoietin (TSLP)180. Recent research suggests that ILC populations have important 
effector functions during the early stages of immune responses against 
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microorganisms151,181, they also contribute to tissue repair182,183, to the anatomical 
containment of commensal microorganisms184 and the maintenance of epithelial integrity 
at barrier surfaces185,186. However, ILCs can also cause inflammatory disorders if 
improperly activated171,187,188. In addition, ILCs have also shown to play a relevant role in 
organogenesis of lymphoid organs in both embryonic development or during 
adulthood147,189,190. Therefore, it is believed that ILCs are exquisitely sensitive to 
environmental cues and continuously adapt to rapidly changing settings, such as the ones 
present at mucosal surfaces. 
 
1.3.2.1 cNK 
In humans, cNKs include the CD56brightCD16- and the CD56dimCD16+ subsets 
present in peripheral blood. CD56bright NK cells are specialized in IFN-γ secretion in 
response to DC/Macrophage-derived cytokines, such as IL-12 and IL-18191 or T cell-derived 
cytokines, such as IL-2192, a functional feature that places them close to other ILC1 
subsets. CD56dimCD16+ NK are specialized in cytotoxicity, since they can readily release 
lytic granules containing perforin and granzyme upon contact with sensitive targets. 
However, it has been shown that CD56dim NKs can also produce IFN-γ, although with a 
more rapid kinetic and in a less sustained fashion than CD56bright NKs193. In addition, it has 
been suggested that CD56bright can differentiate into the CD56dim subset upon 
activation194,195. CD56bright cells produce additional cytokines such as GM-CSF, TNF-α, IL-13 
and IL-10, suggesting that they may have an immunoregulatory function in specific 
circumstances196. 
In the mouse, cNKs include mature and immature circulating splenic and bone 
marrow NKs197, CD127+ IL7-dependent thymic-derived NKs198, and different subsets of 
tissue-resident NKs199,200, whose nature, function, and relationship to other emerging 
subsets of ILC1 are just beginning to be understood. Tissue NKs include an abundant 
population of salivary gland NKs, which are poorly cytotoxic and low producers of 
cytokines201,202, liver-resident CD49a+CD49b- NK cells, and skin- and uterus-resident NK 
cells203. Thymic NKs, for their ability to produce IFN-γ, TNF-α, and GM-CSF in response to 
IL12, are thought to represent the murine counterpart of human CD56bright NK cells. One 
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unifying feature of all NK cell subsets, including thymic NKs204, is their dependence on 
IL-15 and IL-15Rα for development, survival, and maintenance. 
 
1.3.2.2 ILC1  
The identification of bona fide ILC1 in mice was obscured by the fact that ILC1 
were found to express NK receptors such as natural killer cell p46-related protein (NKp46) 
and NK1.1, which have served as an operative definition of NK cells173. Likewise, the same 
has been found in human with ILC1 expressing CD56, NKG2D, NKp46 and C-type lectin 
CD161, typical NK markers172.  
Nevertheless genetic reporter systems for lineage-defining transcription factors 
have allowed us to identify intestinal ILC1 as an ILC lineage separate from cNK cells 
(expressing Eomes reporter) and NKp46-expressing ILC3 (expressing Rorc reporter)159.  
Two major ILC1 subsets have been identified in human: one present in mucosal 
tissues expressing CD127 and CD161, but not expressing other markers of the NK 
lineage172;  plus another population present in tonsillar tissue and characterized by the 
expression of several NK-related markers such as CD56, NKp46, and NKp44173. However 
the latter also expresses markers of tissue-resident memory CD8 T cells such as CD103, 
CD49a, and CD101.  
Although the function of these newly identified subsets of ILC1 have not been 
thoroughly investigated, they may play important pathogenic roles in human 
inflammatory bowel diseases (IBDs) as both CD56-CD127+ and NKp44+CD103+ ILC1 are 
increased in patients with Crohn’s disease, as compared to control individuals172,173. 
 Mouse equivalent subsets have also been found. A potential murine equivalent 
of the CD56-CD127+ human ILC1 has recently been described also in the small intestine 
lamina propria (siLP). These cells are CD127+, but also express markers of the NK lineage, 
such as NKp46 and NK1.1. Interestingly, siLP ILC1, like NKs, depend on IL-15, but not IL-7, 
for their development205,206. In vivo these cells are major producers of IFN-γ and TNF-α in 
response to oral infection with Toxoplasma gondii and promote clearance of this 
pathogen by recruiting inflammatory monocytes159,205. Under these conditions siLP ILC1 
play a major protective role. In addition, the same authors that reported the tonsillar ILC1 
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in humans have also reported an equivalent population present in the mouse small 
intestine.  Murine ILC1 have an intraepithelial location and are distinguished by the 
expression of CD160. Intraepithelial ILC1 are distinguished by cNKs due to the fact that 
they do not respond to IL-12 and IL-18. Alternatively, they secrete large amounts of IFN-γ 
upon stimulation with IL-15. Notably, and contrary to NK, intraepithelial ILC1 are only 
partially dependent on IL-15/IL-15Rα signalling for their development. Interestingly, these 
ILC1 seem to promote tissue damage in a mouse model of colitis induced by CD40 ligation 
in immune deficient mice173. 
 Another subset of ILC1 under debate in the past few years is the so called 
“ex-RORγt ILC3”. In vitro approaches have shown that ILC3, in response to cytokines such 
as IL-15, IL-2, IL-12 and IL-23 that induce IFN-γ production, can be converted into ILC 
type 1172,207. These ILC1 can also be induced in vivo by transfer of RORγt+ ILC3 and 
visualized by fate-mapping experiments in siLP159,208,209. 
 
1.3.2.3 ILC2 
 ILC2 are the most homogeneous ILC class, expressing largely conserved markers 
in all tissues, such as IL-7Rα, CD25, Sca-1, KLRG1, IL-33 receptors ST2, among others153.  
 ILC2 are dependent on the transcription factors GATA-3151 and RORα167,174, TCF-1 
and Notch210  for their development. Functionally, ILC2 are well known to produce IL-5 
and IL-13 in a GATA-3 dependent manner177, as well as IL-4211. ILC2 also produce IL-9, and 
notably, IL-9/IL-9 receptor signalling is required for their survival212. 
 ILC2 can be found in various tissues including adipose tissue-associated lymphoid 
structures151, gut213, lung214 and, as recently described, the dermis50,215,216. They promote 
expulsion of parasites217,218 and maintain lung homeostasis183 or drive airway hyper-
reactivity during viral infections, such as influenza219. ILC2 also contribute to the 
pathogenesis of atopic dermatitis50,215,216. Also in the skin, ILC2 rapidly respond to the 
alarmin IL-33, to the IL-17 family member IL-25 and to TSLP50,215,216. In visceral adipose 
tissue, ILC2 maintain metabolic homeostasis by recruiting eosinophils, which sustain 
macrophage alternative activation220,221. In addition to type 2 cytokines, ILC2 produce 
amphiregulin and support the recovery of epithelial barrier integrity after tissue 
damage183. 
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 In humans ILC2 express CD161 and high levels of the prostaglandin D2 receptor 
CRTH2222. Notably, ILC2 are highly enriched in nasal polyps of patients with chronic 
rhinosinusitis222, suggesting that they might play a fundamental role in human 
Th2-mediated diseases such as asthma and atopic dermatitis. 
 
1.3.2.4 ILC3  
ILC3 are a highly complex group and include many reported subsets in adult mice, 
as well as additional fetal and neonatal LTi subsets that have been recognized as key 
factors for lymphoid organogenesis190. 
ILC3 are grouped together based on shared expression of RORγt, but vary in their 
expression of T-bet, cell-surface markers, and cytokine production profiles. In the adult, 
ILC3 can be found mainly in mucosal tissues, such as the small intestine and large 
intestine, Peyer’s Patches (PP), and gut-associated lymphoid tissue (GALT)47,181,223–225. 
Small numbers of ILC3 are present in the spleen226 and lung227. Curiously, the first ILC3 to 
be characterized was in human tonsils181,223.  
ILC3 subsets include four populations found in greater frequencies in the siLP: 
CD4+ and CD4- subsets of CCR6+NKp46-Rorγt+LTi175, NKp46-Rorγt+T-bet+ ILC3 
progenitors208, and NKp46+Rorγt+T-bet+ Notch-dependent ILC3208,228–230. One additional, 
and very controversial, subset of IL-17 and IFN-γ producing Rorγt+NKp46- ILC3 is present 
in the large intestine231. 
Similarly to ILC1, group 3 ILCs are particularly complicated due to evidence of 
diverging progenitors for different subsets that share many of the same functions and cell 
surface markers. A simplified model of differentiation proposes that there is progressive 
differentiation from NKp46- ILC3, to NKp46+ ILC3, and finally to NKp46+NK1.1+ ex-Rorγt 
ILC3153. In contrast, CCR6+NKp46- LTi do not give rise to NKp46+ ILC3 after transfer208. 
Recent gene expression profiling demonstrated that CD4+ and CD4- NKp46- LTi subsets 
have minimal transcriptional differences and are unlikely to be functionally distinct232. 
However, the developmental relationships between the different subsets within the ILC3 
group will require further experimental approaches. 
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Generally, ILC3 produce the Th17 signature cytokines IL-22 and/or 
IL-1747,181,224,233,234. IL-22 is a member of the IL-10 family of cytokines235, which acts 
through an IL-22 dimeric receptor only expressed by non-immune stromal cells236. Recent 
studies have described that IL-22 mediates barrier integrity during homeostatic 
conditions and mucosal remodeling during injury and infection. In the intestine, ILC3 can 
produce IL-22 upon stimulation with IL-23 produced by inflammatory monocytes and 
CD11+ conventional DCs237,238. The IL-22 produced by ILC3 is absolutely required for 
immunity to attaching-and-effacing bacterial infections239, and together with IL-18 has 
demonstrated novel antiviral functions240. Nevertheless, IL-22 signaling can also be 
pathogenic in certain circumstances, leading to the secretion of neutrophil 
chemoattractants by epithelial cells and dysregulated neutrophil recruitment241. In 
addition, while controlled IL-22-mediated survival and proliferation of epithelial cells may 
favor tissue healing and repair, prolonged IL-22 signaling, and sustained epithelial 
proliferation may drive tumor formation242,243. Notably, tumorigenesis may also be 
increased by ILC3-produced IL-17, as loss of IL-17 in Rag-deficient mice diminishes 
adenoma development244. ILC3 have also been involved in other human diseases, such as 
Crohn’s disease245 and psoriasis246. 
In addition to sensing cytokines released in the surrounding microenvironment, ILC3 
are also sensitive to nutrients. Recent work has shown that vitamin A deficiency results in 
decreased numbers of ILC3 in the intestine, which increases susceptibility to bacterial 
infections247. Moreover, vitamin A intake by pregnant mothers controls the pool of CD4+ 
LTi in the embryos, the size of the lymph nodes and PP, and the efficacy of immune 
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2. Aims of the thesis 
Lymphoid populations have been thoroughly studied in the skin under both steady 
state and inflammatory conditions. DETCs are the major T cell population to exist in the 
murine epidermis in steady state56. However during or after inflammatory conditions, 
resident CD8+ T cells can be found preferentially in the epidermis55. Yet, when looking 
into the dermis, other lymphoid cells can be found such as αβ T cells, NKs and the 
recently described ILC21,50. Here, we have identified, in newborn and adult mice, a new 
lymphoid population present in the epidermis. 
 
In this thesis, we aimed at characterizing this newly discovered population, named 
Epidermal Lymphoid Cells (ELCs).  In detail the aims are: 
1. To understand the nature of this population, having as possibilities all classes of 
lymphoid cells (T cells, ILCs or NKs) 
2. To characterize their phenotype, transcription factor requirements and their 
possible function through cytokine production 
3. To investigate their developmental and homeostatic cues 
 
Taken together, the ultimate goal of this thesis is to understand the true potential of 
this population demonstrating that DETCs are not the only lymphoid population present 
in the epidermis in steady state conditions. Highlighting the presence of another 
lymphoid population in the epidermis may reveal helpful insights in understanding the 
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3. Material and Methods 
Mice 
C57BL/6 (CD45.2) mice (WT) were purchased from the Biological Resource Center (BRC), 
Agency for Science, Technology and Research (A*STAR), Singapore. C57BL/6 (CD45.1), 
B6.Cg-Foxn1nu/J (Nude), B6.129S7-Rag1tm1Mom/J (Rag1-/-), B6.129P-Cx3cr1tm1Litt/J 
mice (Cx3cr1gfp/+), B6.129P2(Cg)-Rorctm2Litt/J (Rorc-/-) were purchased from the Jackson 
Laboratory (Jackson Laboratory, Bar Harbor, USA). B6.129S6-Rag2tm1Fwa N12 (Rag2-/-) 
were purchased from Taconic (Taconic Farms, USA). Rag1-/- mice were crossed with 
C57BL/6 CD45.1 to give rise to congenic Rag1-/- CD45.1 mice as well as with Cx3cr1gfp/+ 
mice to create Rag1-/-Cx3cr1gfp/+ mice. NOD scid gamma (NSG) were kindly obtained from 
SIgN Mouse Core facility. Runx3-/- mice were kindly obtained from Dr. Motomi Osato, 
National University of Singapore. All mice were bred and maintained in the SIgN animal 
facility, and analyzed at late embryogenesis (E17.5 and E18.5), newborn stage, 6 days 
after birth and adult at 8-12 weeks old (wo). All experiments and procedures were 
approved by the Institutional Animal Care and Use Committee (IACUC) of A*STAR 
(Biopolis, Singapore) in accordance with the guidelines of the Agri-Food and Veterinary 
Authority (AVA) and the National Advisory Committee for Laboratory Animal Research 
(NACLAR) of Singapore. All the Il15Ra-/- mice were kindly provided by Dr. Melanie Greter 
and bred at Institute of Experimental Immunology, Department of Myeloid Cell 
Immunology, University of Zurich, Switzerland. All the pTα-fate mapping mice248 were 
kindly provided by Dr. Hans Jörg Fehling and bred at the Institute of Immunology, 
University Clinics Ulm, Germany. Both Tbx21-/-249 and Nfil3-/-250 mice were kindly provided 
by Dr. Laura Mackay and bred at the University of Melbourne, Australia.  
 
Flow cytometry, cell sorting and intracellular cytokine staining 
Flow cytometry was performed on an LSR II 5 lasers and Aria II 4 or 5 lasers (Becton 
Dickinson, San Jose, USA) and analyzed with FlowJo software (Tree Star, Ashland, USA). 
Fluorochrome-conjugated monoclonal antibodies (mAbs) specific to mouse CD45 (30F11), 
CD45.1 (A20), CD45.2 (104), CD2 (RM2-5), CD3 (145-2C11), CD4 (GK1.5), CD8 (53-6.7), 
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CD48 (HM48-1), CD49b (DX5), CD90.2 (53-2.1), TCRβ (H57-597), TCRγ/δ (GL-3), Vγ3 (536), 
CD103 (2E7), CD244 (244F4), CD278 (C398.4A), NK1.1 (PK136), IL-2Rβ (TMb1), IL-2 
(JES6-5H4), IFN-γ (XMG1.2), IL-13 (eBio13A), TNF-α (MP6-XT22) were purchased either 
from BD Biosciences (San Jose, USA) or Ebiosciences (San Diego, USA). DAPI labeling was 
used to exclude dead cells. Intracellular labeling for CD3, IL-2, IFN-γ, IL-13 and TNF-α was 
performed on cells previously labeled for surface markers, following fixation and 
permeabilization with Fix/Perm solutions (BD Biosciences, Mountain View, CA) according 
to the manufacturer's instructions. Intracellular cytokine staining was performed on 
epidermal cell suspensions after stimulation for 4 hr with phorbol myristate acetate 
(PMA) (500 ng/mL) and ionomycin (500 ng/mL) (Sigma-Aldrich). For the last 2h of 
stimulation Brefeldin A (1 ng/mL) (Sigma-Aldrich) was added to the stimulated wells 2h 
after PMA and ionomycin was added. 
 
Mouse skin cells preparation  
Mouse skin cells were isolated as described previously251. Briefly, embryonic/neonatal 
skin was detached from the body or adult mouse ears were split into dorsal and ventral 
halves and floated in RPMI-1640 medium (Sigma-Aldrich) containing 1 mg/ml dispase 
(Invitrogen) for 60 min to allow separation of epidermal and dermal sheets. Epidermal 
and dermal sheets were then cut into small pieces and incubated in RPMI containing 10% 
fetal calf serum (FCS), 0.8 mg/ml collagenase type IV (Sigma-Aldrich) and 50µg/ml DNase I 
(Roche) for 90min. Cell suspensions were then syringed through a 19-gauge needle and 
filtered through 70µM cell strainer (BD Falcon) to obtain a homogeneous single cell 
suspension. For purpose of cell number normalization, analyses were performed on both 
ears of the adult mice and the corresponding area, 3cm2, of the body skin from the 
embryos and newborn mice. 
 
Intravital multiphoton imaging of mouse ear skin  
Mice were anaesthetized with a cocktail of 150 mg/kg ketamine and 10 mg/kg xylazine, 
before ear hair was removed with depilatory lotion Veet. Anaesthetized mice were 
immobilized on a custom-made stage252 with a heating pad attached to maintain animal 
temperature at 37°C. To label blood vessels in vivo, mice were retro-orbitally injected 
with 40 μl of 10 mg/ml of Evans Blue dye (Sigma-Aldrich). Images were acquired using a 
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multiphoton microscope system (LaVision Biotec) with a tunable Chameleon Ultra II 
Ti:Sapphire laser (Coherent) at 950 nm, and the following long pass mirrors and bandpass 
filters: 495 LPXR (Chroma), 560 LPXR (Chroma); 475/42 (Semrock) , 525/50 (Chroma), 
655/40 (Semrock). Data sets generated were analyzed by IMARIS image analysis software 
(Bitplane). 
 
Generation of bone marrow chimeras 
Recipient 7 to 8 week old (wo) CD45.2 Rag1-/- were lethally irradiated (2x 600 rad, 3 hours 
apart using a Cesium source) and reconstituted by intravenous injection with 1x106 cells 
of CD45.1 WT BM. Engraftment was assessed by measuring the percentage of donor cells 
among blood CD45+ cells 4 weeks after transplantation. Adult recipients were analyzed 
two or six months post-transplant. Proportion of DETCs, ELCs and ILCs derived from WT 
(CD45.1) cells was determined.  
 
Generation of parabiotic mice 
CD45.2 Rag1-/- mice were sutured to either CD45.1 WT or CD45.1 Rag1-/- and were left 
together for four months before analysis. All mice were 5 to 6 wo at the time of surgery. 
Mice received 150 mg/kg ketamine and 10 mg/kg xylazine as an anesthetic plus 
buprenophine and baytril were injected intradermal for a few days after surgery. 
 
Generation of Rosa26-Rag mice for inducible Rag1/2 activity 
In order to generate a mouse line in which Rag1 and Rag2 expression can be induced 
from the Rosa26 locus by removal of the STOP cassette upon Cre expression, we used  2A 
peptides253 for bicistronic expression. We amplified mouse Rag2 coding region from 
mouse genomic DNA by PCR reaction with primers (Rag2-5’ and Rag2-2A-3’) which 
allowed us to added 2A peptide sequences after the stop codon for Rag2 translation. We 
also amplified Rag1 cDNA by PCR. These PCR products were cloned into the pCR-TOPOII 
vector (Invitrogen), and their sequences verified. We then inserted Rag2-2A fragment in 
front of Rag1 cDNA fragment in pCR-TOPOII, followed by preparation of an entire 
Rag2-2A-Rag1 fragment by NotI digestion and a ligation into the NotI site of pCTV vector 
(Addgene) (Figure S2a). The linealized targeting vector was transfected into M1 
embryonic stem (ES) cells by electroporation. After G418 selection, ES clones that 
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underwent homologous recombination were screened by PCR as previously described254. 
Appropriate ES cell clone was used to generate the chimera mice.      
Primers: Rag2-5’ (5’- CGGCGCGCC AGCATAATTACCAATATGAAAAGATATTC -3’), Rag2-2A-3’ 
(5’- CGGATCCCCTGGGCCAGGATTCTCCTCGACGTCACCGCATGTTAGCAGACTTCCTCTGCCCT 
CTCCACTGCCATCAAACAGTCTTCTAAGGAAGGATTTC-3’), Rag1-5’ (5’-GGATCCTATGGCTGCC 
TCCTTGCCGTCTACCCTGAGC-3’) and Rag1-3’ (5’- CGGCGCGCCATGTGGAGATCCTATTTAAAA 
CTCCATTGA -3’). 
 
In vitro recombination assay  
To measure Rag1/2 activity from Rosa26-Rag1A2 locus that was induced upon Cre 
expression, we used a recombination template vector, pJH200255. Embryonic feeder cells 
generated from E13.5 embryos, which harbor WT or heterozygous for Rosa26-Rag alleles, 
were transfected with pJH200 with or without Cre expression vector, pMC-Cre, by 
FuGENE reagent (Promega) (Figure S2b). Three days after transfection, cell lysates were 
prepared and were analyzed for Rag-dependent recombination events by PCR as 
previously described255.     
 
Stromal Culture 
Stromal cell culture methods were modified from256. In brief, TSt4/DL1 cells (kindly 
obtained from Dr. Ikawa, RIKEN Institute, Japan) were co-cultured for 9-12 days with 
purified ELCs, from WT newborn epidermis, in the presence of 10ng/ml IL-2, 10ng/ml IL-7, 
and 10ng/ml IL-15 (R&D systems), in RPMI media supplemented with 10% FCS, 2mM 
L-glutamine, 1mM sodium pyruvate, 2mg/ml sodium bicarbonate, 0,1mM nonessential 
amino acids, 50 μM 2-mercaptoethanol, 100 U/ml penicillin, and 100 mg/ml 
streptomycin. 
 
Fetal Thymic Organ Cultures (FTOC) 
The experiment was performed as described257. In summary, 2-deoxyguanosine-treated 
E15.5 fetal thymic lobes from CD45.1 WT were cultured for 7 days before reconstitution 
with purified ELCs from CD45.2 WT newborns. Around 10 to 15x103 ELCs were added to 
the thymic culture by the hanging-drop technique over 24h and then cultured for 12 to 15 
days. RPMI-1640 medium (Sigma-Aldrich) supplemented with 10% of Hyclone FCS (GE 
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Healthcare Life Sciences), 5μM 2-mercaptoethanol, 10 mM Hepes, 2mM L-glutamine, 
100 U/ml penicillin and 100 μg/streptomycin was used throughout the culture. Medium 
was additionally supplemented with 1.35mM of 2'-deoxyguanosine (dGuo, Sigma-Aldrich) 
to treat the E15.5 thymic lobes. Treatment with dGuo selectively eliminates thymocytes, 
interdigitating cells and DCs from the thymic cultured tissue, allowing the introduction of 
new hematopoietic progenitors to the fetal thymic stromal environment. 
 
NanoString 
Direct mRNA expression levels of the samples were measured using the NanoString 
nCounter gene expression system. 6-10x103 cells in 5uL of RLT buffer were hybridized 
with probes from the nCounter Mouse Immunology panel V1 at 65oC for 17 hours 
according to the nCounter™ Gene Expression Assay Manual. Post-hybridization processing 
were done using the nCounter Prep Station (GEN1) and the nCounter Digital Analyzer 
(GEN1). Four lanes of NanoString data were obtained as RCC files and processed using 
BIOVIA Pipeline Pilot. The geometrical means of the positive control probe counts were 
computed for each lane and a scaling factor computed for each lane being the average of 
the geometrical means of all lanes divided by the geometrical mean of that particular 
lane. This scaling factor was then applied to all probe counts for all lanes as a means to 
normalize for the technical variability of the platform. The house keeping genes Cltc, 
Gapdh, Gusb, Hprt, Pgk1 and Tubb5 were then used to normalize for any RNA loading 
differences. This was performed in the same manner as the positive control probes where 
the scaling factor was computed from the geometrical mean of the house keeping genes. 
The positive control and housekeeping normalized counts were then logarithmically 
transformed and used for all subsequent analysis. Data visualization was performed using 
TIBCO Spotfire. Threshold was set at 100 average counts to define high expression, ten 
times higher than the control. 
 
Statistics 
Statistical analysis was performed on GraphPad Prism6. Mann-Whitney tests were 
performed using unpaired experimental designs with non-parametric tests. Significance 
was defined at p<0.05 (ns p>0.05, * p≤0.5, ** p≤0.01, *** p≤0.001 and **** p≤0.0001). 
Unless specified all error bars in graphs represent Standard Error of the Mean (SEM). 
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4. Results 
4.1 Murine epidermis contains a population of Thy1+ cells that are distinct from DETCs 
The mouse epidermis has two major hematopoietic populations under steady state 
conditions, DETCs and LCs, which together with keratinocytes work together towards 
immune defense of the skin.  
The Rag-deficient models lack all T and B cells258,259, including DETCs, being 
therefore believed to be depleted of any lymphoid population in their epidermis. 
However, when analyzing the Thy1 expression in the epidermis of wild type (WT) and 
Rag-deficient models we identified a significant population of Thy1+, CD3- and TCRβ- cells 
(Figure 5a). Even though these cells were present in the WT epidermis, they existed at 
much lower frequencies compared to the accumulated population found in the 
Rag-deficient models. Curiously, this population expressed CD103, an integrin broadly 
expressed by intraepithelial lymphocytes260–262. However, while the fractalkine receptor 
CX3CR1 was also expressed at high levels by 100% of these cells in the Rag-deficient 
animals, in the minor Thy1+ population from the WT, expression was variable and 
restricted to a fraction of the cells (Figure 5b).  
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Using the Cx3cr1gfp/+ reporter model, we investigated their cell distribution in the 
Rag1-/- epidermis. In the WT, DETCs are positive for CX3CR1 and therefore these mice 
exhibited a uniform network of GFP+ cells. Interestingly, the Rag1-/-Cx3cr1gfp/+  epidermis 
revealed only a few clusters of GFP+ cells, having also patches that were completely 
lacking any CX3CR1 (Figure 6a). We hypothesize that these clusters might be the result of 
clonal expansion of different progenitors that arrived in the skin. 
While investigating their cell morphology and sphericity, we observed that 
Thy1+CD3- cells in the Rag1-/- are more spherical than WT DETC (Figure 6b and c). Such 
detailed analysis of the morphology of the WT Thy1+CD3- population was not possible due 
to the fact that these cells are rare, have a heterogeneous expression level for CX3CR1, 
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4.2 Differential CD2 expression sub-divides the minor epidermal Thy1+ population 
ILCs are part of the lymphoid family that expresses the Thy1 molecule. Thus we 
questioned whether the newly identified Thy1+ population could be part of this family of 
cells.  
ILCs are known to have morphological characteristics of lymphoid cells yet lack the 
rearranged antigen receptor. In addition, ILCs can be divided into three main groups 
based on the transcription factors involved in their development, as well as their 
produced cytokines180,263,264. Analyses of peripheral tissues have shown that ILCs are 
spread throughout the body, being more prominent in mucosal areas that harbor more 
than one group of ILC153.  
Recently, ILC type 2 has been described in the dermis, as Thy1hiCD3-CD2-ICOS+50, a 
similar phenotype to epidermal Thy1hiCD3- cells. Using the same gating strategy as 
Roediger et al50 (Figure S1), we identified in both Rag1-/- and WT dermis two populations 
expressing high levels of Thy1 and negative for CD3: a CD2+ (blue) and a CD2- (red). 
However both populations were positive for ICOS (Inducible T-cell COStimulator). 
Nevertheless, the same populations could be found in the epidermis of both WT and 
Rag1-/- mouse models (Figure 7a). In contrast to what we observed in the dermis, while 
the minor CD2- population was positive for ICOS, likely corresponding to ILC2; the major 
CD2+ population was negative for ICOS (Figure 7a). Thus, the majority of the novel Thy1+ 
population that expresses the intercellular adhesion/T cell activation molecule CD2, and 
lacks ICOS, is distinct from both DETCs and ILCs in the murine epidermis. Thus we 
conclude that these cells represent a novel and discrete population, which we have 
termed Epidermal Lymphoid Cells (ELCs). 
Upon these new results we can conclude that both WT and Rag1-/- epidermis 
harbour a fraction of CD3 negative cells that include ELCs which express high levels of 
CX3CR1 and ILCs that have a heterogeneous profile of the same fractalkine receptor 
(Figure 7b). 
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shown. b. Histograms show relative expression of CX3CR1 among ELC and ILC populations in WT (red) and 
Rag1
-/-
 (blue) models. Representative data from n>3. 
 
The genetic ablation of Rag genes causes an intrinsic defect in T and B cell 
maturation in the context of otherwise normal immune anatomy. Contrastingly, the Nude 
mouse model is rendered effectively athymic by a mutation in the Foxn1 gene that results 
in defective development of the thymic epithelium and the almost complete absence of T 
cells265,266. Interestingly, we analyzed epidermal cell suspensions of Nude mice and 
observed that, similarly to the Rag1-/-, their epidermis also harbored a heterogeneous 
Thy1+ population with a fraction of CD2+ cells and ICOS+ (Figure 8a and b).  Consequently, 
we can possibly conclude that our population is thymic independent. 
Given the thymic-independence of ELC generation, we asked which other 
components of the immune differentiation pathways these cells were reliant upon. The 
common gamma chain (γc), also known as IL-2R gamma (IL2Rγ), is a cytokine receptor 
subunit that is common to the receptor complexes for at least six different interleukin 
receptors: IL-2, IL-4, IL-7, IL-9, IL-15 receptors267–272. In consequence, γc-deficient mouse 
models, such as NOD scid gamma (NSG), lack all mature T cells, including DETCs, 
implicating that γc receptors do play an essential role in development of the DETC 
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combining the features of the NOD/ShiLtJ background, the severe combined immune 
deficiency mutation (scid) and Il2rg deficiency. Hence, we tested if ELC were also 
γc-dependent. Examining the epidermis of NSG mice revealed a complete lack of Thy1
+ 
cells (Figure 8a and b). As a result ELCs were also completely absent in these animals, 
meaning that this population is dependent on the IL2Rγ for its survival or maintenance.  
In addition, deletion of IL-15, IL-15Rα, or IL-2Rβ results in a block of NK cell 
development and impaired γδ T cell development in the epithelium274–276. Previous 
studies have shown that IL-15/IL-2Rβ plays an essential role in either maturation of Vγ3+ T 
cells in the fetal thymus or in expansion and/or survival of DETCs in the skin277. Therefore, 
we proceeded with the analysis of the epidermis of Il15ra-/- mice. As expected, these mice 
had no DETCs in their epidermis but their CD3- fraction could still be split into the same 
two populations as the other mouse models analyzed previously (Figure 8a). Curiously, 
ELCs were reduced in these mice (Figure 8b). 
Thus, we conclude that ELCs are different from the skin ILC2 previously identified, 
are thymic independent but IL-2Rγ and IL-15Rα dependent. 
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Figure 8. Presence of ELC in different animal models. 
a. Flow cytometry of mouse epidermal cell suspensions of different 8wo mouse models. Representative 
gating strategies to identify ELC or ILC populations. b. Absolute numbers of ELCs and ILCs
 
within the 
hematopoietic compartment in different animal models. Each data point represents an individual mouse. 
Representative data from n>3, except for NSG mice where n=2. 
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4.3 ELCs are radioresistant and possess self-renewal capacity 
DETCs, similarly to Langerhans cells, are resistant to radiation. Both populations are 
derived from embryonic progenitors and renew themselves locally, not being replaced by 
any circulating/transplanted bone marrow progenitor278,279.   
Due to the unique characteristics of these epidermal subsets, we decided to test if 
ELCs share similar homeostasis cues with DETCs. By further characterization of the 
homeostasis of this population we hope to gain insight on their origin and nature.  
Firstly, we generated bone marrow chimeras by reconstituting lethally irradiated 
Rag1-/- mice with WT bone marrow. Analyzing the epidermis 2 months after transplant 
revealed that, as expected, all the T cells found in the epidermis were from donor origin. 
Unsurprisingly 80% of the ILC population was also replaced by the donor cells (Figure 9), 
as ILC susceptibility to radiation has been described previously50. However, ELCs remained 
from the host 2 months after reconstitution (Figure 9). Similar observations were made at 
longer time point after transplantation (6 months), suggesting that the ELCs maintain 
themselves locally, independently of bone marrow input, in contrast to ILCs (Figure 9). 
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Figure 9. ELCs are radioresistant. 
a-b. Flow cytometry data showing percentage of CD45.2 and CD45.1 T cells, ILCs and ELCs in mouse 
epidermal cell suspensions from BM chimeric mice (CD45.1 WT:CD45.2 Rag1
-/-
) (2 months n=6; 6 months 
n=7). Each data point represents an individual mouse. 
 
Bone marrow chimeras are often informative, but the process of irradiation and 
reconstitution results in an inflammatory environment that introduces experimental 
artifacts280. Therefore we also assessed the homeostatic turnover of epidermal cell 
populations using parabiotic mice. In this model, two adult congenic mice differing in 
expression of CD45 antigens, for example, are surgically attached in order to link their 
circulatory systems. This technique enables measurement of the extent of the 
contribution made by blood-borne cells from each parabiont to immune cell populations 
in the other, over prolonged periods and without the need for irradiation. 
We joined congenic wildtype CD45.1 and Rag1-/- CD45.2 mice surgically and 
assessed the presence of non-host cells in the Rag1-/- four months later. As predicted all 
the T cells found in the Rag1-/- epidermis were from donor origin, while ILCs showed some 
heterogeneity in their ability to exchange between circulations. Surprisingly, 100% of the 
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To exclude the possibility that WT mice, which bear fewer ELCs than their Rag1-/- 
counterparts (Figure 5a), were simply unable to provide the appropriate blood-circulating 
precursor for ELCs, we confirmed our findings in Rag1-/- CD45.1 and Rag1-/- CD45.2 
parabionts. Similarly, after four months, ELCs in the epidermis of both mice remained of 
host origin (Figure 10c-d). In summary, ELCs, similarly to DETCs and LCs, are resident cells 
that do not undergo replenishment from precursors arising from bone marrow or borne 
in the blood, either following irradiation or during prolonged periods of parabiosis. 
 
 
Figure 10. ELCs renew themselves locally. 
a-b. CD45.1 WT mice were joined surgically with CD45.2 Rag1
-/-
 mice to create parabiont pairs. Four months 
later flow cytometric analysis was performed on epidermal cell suspensions from the Rag1
-/-
 mice, assessing 
the contribution of the donor to the cell pool. n=6. c-d. Parabiosis was performed with CD45.1 and CD45.2 
Rag1
-/-
 mice. Four months later epidermis from both mice was analyzed by flow cytometry. Representative 
plots of the donor contribution into the epidermal cell composition of each mouse. n=4. Each data point 
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4.4 ELCs express heterogenous levels of T lineage markers 
Since ELCs shared such unique characteristics with DETCs and expressed lymphoid 
markers we wondered if this population could belong to the T cell or T cell progenitor 
family.  
Several studies have shown that T cell progenitors, in the adult or embryonic 
thymus, express CD3ε intracellularly281,282 or that intracellular CD3 can be a hallmark of  
lymphoid cells belonging to the T cell lineage283. Therefore, we investigated whether this 
population expressed CD3 in their cytoplasm.  
WT, Rag1-/- and Nude mice epidermal cell suspensions were analyzed by flow 
cytometry. Results were striking; while cytoplasmic expression of CD3ε in the ELC 
population varied between 25 to 40% in all models, ILCs did not express any intracellular 
CD3ε (Figure 11a-b).  
 
 
Figure 11. ELC population expresses CD3ε intracellularly. 
a. Flow cytometry of WT, Rag1
-/-
 and Nude epidermal cell suspensions with intracellular labeling for CD3ε. 
Histograms represent the percentage of cells that express CD3ε in their cytoplasm in the ELC and ILC 
populations. Representative flow cytometry plots from n=5. b. Dot plot showing the expression of CD3ε 
intracellularly within the ELC population in WT (red), Rag1
-/-
(blue) and Nude (green) mouse models. Each 
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Another phenotypic characteristic that links a cell’s nature to the T cell lineage is 
the expression of pre-TCRα (pTα). The pTα chain is an essential and invariant subunit of 
the pre-TCR284. The only known physiological function of pTα protein is to associate with 
nascent TCRβ chains in committed T lineage progenitors. Together they form a functional 
pre-TCR, which provides essential signals to promote development of αβ thymocytes and 
to regulate αβ/γδ lineage choice. In line with this highly restricted function, pTα 
expression is largely confined to immature thymocytes. On top of that, another study has 
shown that pTα expression is found in pro-T cells outside the thymus as well as in intra- 
and extra-thymic sites of T cell development285.  
Therefore, we took advantage of a CRE based  fate mapping system of pTα, where 
all cells that have expressed pTα are heritably marked 248. To visualize iCre expression, 
PtcraiCre knockin mice were intercrossed with Rosa26tdRFP reporter line286 (Figure 12a-b). 
As a negative control Rosa26tdRFP/tdRFP mice lacking iCre expression were used. By 
analyzing 8wo mice, we observed that, as expected, all αβ T cells expressed pTα. However 
DETCs also express nearly 100% (Figure 12). It is controversial whether γδ T cells can 
express pTα, and even though some evidence of that has been published287–289, the 
precise number of γδ T cells which pass through a pTα-expressing developmental stage, 
under physiological in vivo conditions, has not been determined yet. Under our 
experimental conditions, we can conclude that all DETCs pass by a pTα-expressing 
developmental stage. Intriguingly, ELCs also partially expressed pTα, around 12%. ILCs 
also exhibited a small expression of pTα, around 4% (Figure 12). 
We also analyze the same fate mapping model in a Rag1-/- background. However, 
ELCs had no pTα expression in this model. We hypothesize that the lack of the Rag1 
expression may limit the ability for ELCs to proceed in the normal development of T cells. 
Possibly the Rag expression is upstream of the Ptrca, leading to limitation of the 
expression of this protein in these cells. 
Thus, partial expression of CD3ε intracellular and pTα led us to presume that ELCs 
are a pool of T-lineage committed cells that, for unknown circumstances, are incapable of 
continuing down the T cell development pathway. 
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Figure 12. ELC population patially expresses pTα. 
a. Strategy for the pTα
iCre





c. Representative flow cytometry plots to identify pTα-expressing cells in the mouse epidermis. The 
histograms and the dot plots show the expression of pTα within the αβ T cell (red), DETC (blue), as well as 
ELC (green) and ILC (orange) populations. Each data point represents an individual mouse. Data were 
obtained from n=4 of Rosa26
tdRFP/tdRFP
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4.5 Adult ELCs do not differentiate into T cells 
The fate mapping data showed that some of the ELCs from WT mice had 
differentiated sufficiently far down the T cell pathway to express pTα. However, this was 
not the case in Rag1-/- mice, perhaps because the lack of Rag expression created an 
intrinsic block at a stage preceding pTα expression. 
In an attempt to rescue ELC development in Rag1-/- mice, we developed a 
Rag-inducible model (Figure S2, see material and methods section).  A DNA fragment 
containing 2A peptide sequences between Rag1 and Rag2 cDNA after the loxP flanked 
Stop cassette was inserted into the Rosa26 locus of WT Embryonic Stem (ES) cells. The 
resulting mouse model was crossed to Rag1-/- Rosa26Cre-ERT2/+ 290, resulting in Rag1+/- mice 
harboring an inducible Cre-ERT2 transgene or the stop-Rag1A2 fragment in their Rosa26 
locus, respectively. Mice were then further intercrossed to obtain the desired genotype, 
the Rag-inducible model on Rag1-/- background (Figure 13).  
Upon tamoxifen administration that activates the Cre recombinase, these mice 
produce both Rag1 and Rag2 protein from Rosa26Rag1A2 allele as well as express GFP as a 
reporter of recombination, allowing identification of Rag-expressing cells by flow 
cytometry (Figure 13). 
We hypothesized that by inducing expression of the Rag genes that the cells were 
missing, the developmental potential of ELC would be restored, with the possibility of 
proceeding from their double negative (DN) CD4-CD8- status to the DP291, or subsequent 
single positive CD4 (CD4+CD8-, SP CD4+) or CD8 (CD4-CD8+, SP CD8+) stages292. 
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Figure 13. Rag-inducible model strategy.  
Rag1
-/-
 mice were crossed with WT mice either with a cre-ERT2 insertion or a stop-Rag1A2 insertion into 





). Upon tamoxifen administration the Cre recombinase becomes active leading 
to the re-expression of the Rag genes that can be identified by flow cytometry by the expression of the GFP. 
 
Rag gene expression in our inducible model was induced by intraperitoneal (i.p.) 
administration of Hydroxytamoxifen (4’OHT) for 5 consecutive days. On month later, both 
thymus and epidermis of WT, Rag1-/- and the Rag-inducible mice were collected and their 
cell populations analyzed by flow cytometry. 
By analysis of the WT thymocytes, we could observe a normal T cell development, 
where TCRβ expression was restricted to SP stage, a sign of T cell maturation (Figure 14). 
In the Rag1-/-, due to the absence of the Rag1 gene, thymocytes were, as expected, 
arrested at the DN stage (Figure 14). Approximately one third of thymocytes in the 
Rag-inducible model expressed GFP, and 12% of these thymocytes had proceeded to the 
DP stage, while all thymocytes in the Rag1-/- were arrested at the DN stage (Figure 14). 
Furthermore, in the Rag-inducible mice, 0.5-1% of thymocytes achieved SP expression of 
CD4 or CD8 with TCRβ expression (Figure 14), showing that our rescue model was able to 
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Figure 14. Rag-inducible model can rescue T cells in the thymus. 
Mice were injected i.p. with tamoxifen daily for 5 days and thymocytes were analyzed 30 days later by flow 
cytometry. GFP signal indicated Rag recombination and expression. Representative flow cytometry plots of 
thymocytes of WT and Rag1
-/-
 controls, as well as the Rag-inducible model are shown. Data representative 
of 3 independent experiments with 2 mice each. 
 
Next we analyzed the epidermis of the same mice. While selecting the ThyhiCD2+ 
cells in the WT we have included DETCs. Therefore, the results were unsurprising; these 
cells were CD4-CD8-TCRβ- but TCRγ+CD3+ (Figure 15). In the Rag1-/- these cells were 
negative for all the markers analyzed (Figure 15). However, in the Rag-inducible model 
ELCs exhibited comparable phenotype regardless of the induction of Rag expression 
(Figure 15): even upon reinstatement of the Rag genes, no change in expression of 
markers linked to T cell maturation, such as TCR or CD3, was observed (Figure 15). Later 
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Figure 15. Rag-inducible model fails to rescue T cells in the epidermis. 
Mice were injected i.p. with tamoxifen daily for 5 days and epidermal cell suspensions were analyzed 30 
days later by flow cytometry. GFP signal indicated Rag recombination and expression. Representative flow 
cytometry plots of WT and Rag1
-/-
 controls, as well as the Rag-inducible model are shown. Data 
representative of 3 independent experiments with 2 mice each. 
 
 
Hence, we believe that either ELCs are not T cell progenitors or the adult skin 
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4.6 ELCs are present in the murine epidermis prior to birth 
DETCs arise from embryonic precursors and self-maintain into adulthood 278,293,294. 
Given the homeostatic similarities we uncovered between ELCs and these cells, we asked 
whether ELCs might also seed the skin prior to birth. To pursue this new hypothesis we 
analyzed the epidermis of both WT and Rag1-/- before and right after birth, at E17.5 of 
embryonic life, newborn (NB) and adulthood (Figure 16a-b). 
Within the CD45+Thy1+ pool of cells the presence of T cells was assessed through 
the expression of CD3. To confirm that the CD3+ cells found in the WT epidermis at E17.5 
were DETCs, we verified the expression of their specific γδ TCR, Vγ3. As has been reported 
in the literature294, DETCs appear in the epidermis as early as E17.5 and reside there 
throughout development. Curiously, at the same timepoint, a CD3-Vγ3- population was 
also found in the WT and Rag1-/- epidermis (Figure 16a). Throughout development, the 
WT CD3-Vγ3- population slightly increases its frequency at birth but rapidly decreases 
during adulthood. In the Rag1-/- epidermis these cells followed a similar pattern to the 
one observed by DETCs in the WT epidermis, increasing its frequency throughout 
development (Figure 16b). 
 
 






 population is present before birth in both WT and Rag1
-/-
 models.  





are shown throughout mouse development. b. Absolute numbers of both populations during late 
embryogenesis, newborn and adult mice are shown for WT (red) and Rag1
-/-
 (blue). Representative data 
from n>3. 
 
To further characterize this CD3-Vγ3- population and to understand if the 
heterogeneity observed in the adult was the same earlier in life, we explored the 
expression of CD2 and ICOS. Results were striking as hardly any ILCs were present before 
birth, showing that 70% of the CD3-Vγ3- cells were positive for CD2 in the WT epidermis, 
corresponding to the ELCs previously observed in the adult epidermis. The same was 
observed in the Rag1-/- epidermis before birth (Figure 17a). At the newborn (NB) stage 
the frequency of ELCs increased, further expanding until six days after birth (D6) in both 
models. However, by adulthood, ELC frequency had decreased, reaching almost 
undetectable numbers in the WT (Figure 17b). ILCs are only properly detected after birth, 
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Figure 17. ELC population is present before birth in both WT and Rag1
-/-
 models.  




 population in 
the mouse epidermis of both models, WT and Rag1
-/-
. b. Absolute numbers of both populations in late 
embryogenesis (E17.5), newborn, day6 and adult mice for WT (red) and Rag1
-/-
 (blue). Representative data 
from n>3. 
 
 In addition, we screened different tissues of WT NB mice in order to understand if 
this population was restricted to the epidermis. This hematopoietic population of 
ThyhiCD3-αβ/γδTCR-CD2+ cells was detected in tissues where T cell progenitors are 
abundant such as the thymus. However, the epidermis stood out as presenting a high 
ratio of ELCs among the pool of CD45+ cells in the different tissues (Figure S3). 
 Altogether we can conclude that in late embryogenesis and after birth, WT mice 
have a population of ELCs in similar frequencies as the Rag1-/- mice. These findings are in 
concordance with a theory that ELCs and DETCs might be competing for the same niche, 
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4.7 Embryonic ELCs do not express extracellular CD3ε but express pTα 
To understand if, similarly to the ELCs found in the adult, the embryonic 
population of ELCs was bound to the T cell lineage, we analyzed late embryogenesis time 
points for the CD3ε expression in their cytoplasm as well as the pTα fate mapping model 
previously used.  
Epidermis from WT embryos at E17.5 was analyzed by flow cytometry for the 
presence of CD3ε intracellular in the DETC and ELC populations. As expected, DETCs had 
close to 100% expression of CD3ε in their cytoplasm (Figure 18a-b). However, at this 
stage, the presence of intracellular CD3ε in the ELC population was barely detectable 
(Figure 18a-b). We hypothesize that before birth it is too early for these progenitors to 
start expressing CD3ε in their cytoplasm. Nevertheless, NB WT mice were also analyzed 
exhibiting the same results (data not shown) dismissing such hypothesis. 
 
 
Figure 18. Embryonic ELCs do not express CD3ε in their cytoplasm.  
a-b. Flow cytometry of mouse epidermal cell suspensions with intracellular labeling for CD3ε of E17.5 WT 
embryos. Histograms and dot plot identify the percentage of CD3ε intracellular expression of both DETC 
(blue) and ELC (green) populations. Each dot represents one individual embryo. Representative data from 
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 Even though ELCs did not express CD3ε in their cytoplasm we wondered if they 
would express pTα before birth, similar to the adult population. We proceeded with flow 
cytometry analysis of the epidermis of E18.5 embryos of the pTα fate mapping model 
used previously. Our results showed that already at this time point DETCs were nearly 
100% positive for pTα. However ELCs showed to be heterogeneous for pTα expression, 
with an average of 35% expression (Figure 19a-b). 
 
 
Figure 19. Embryonic ELCs express pTα. 
a-b. Gating scheme to identify pTα expressing cells in the E18.5 mouse epidermis. The histograms and dot 
plot identify pTα-expressing cells within the DETC (blue) as well as ELC (green) populations. Each data point 







Thus, we conclude that embryonic ELCs in the WT seem to belong to the T cell 
lineage due to the fact that these cells do express pTα. The lack of CD3ε expression in 
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4.8 Neonatal ELCs do not differentiate into T cells 
Since neither adult nor embryonic skins seem to provide the correct environment 
for the ELC population to further develop and to reveal a potential intrinsic loss during 
development in the skin, we decided to address this question through in vitro and ex vivo 
experimental designs. 
Purified ELC population from WT NB epidermis was co-cultured with TSt-4 stromal 
cells expressing Delta-like 1 (TSt4/DL1). The fibroblastoid cell line TSt-4, established from 
fetal thymus tissue of C57BL/6, expressing delta-like 1 (DL1), has shown to support the 
development of T cell progenitors into mature T cells295. Cytokines such as IL-2, IL-7 and 
IL-15 were added to the culture in order to promote the development of these T cell 
progenitors. After 9 to 12 days in culture the ELC population maintained its phenotype, 
lacking any maturation markers of the T cell lineage, such as CD3 or TCR (Figure 20). 
 
 
Figure 20. ELCs co-cultured with TSt4/DL1 stromal cell line. 
Progeny of ELCs co-cultured for 9-12 days with TSt-4/DL1 stromal cells were analyzed by flow cytometry. Expression 
levels of CD4, CD8 and mature T cell markers such as TCR and CD3 were analyzed. Data representative of n=3. 
  
Fetal thymic organ cultures (FTOC) have been used for over 25 years to address 
scientific questions regarding the mechanisms of T cell development. For example, FTOC 
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liver296. Therefore, these culture systems are considered the most accurate way to 
address the nature of a T cell progenitor ex vivo. 
We cultured E15.5 thymic lobes from CD45.1 WT mice with 2'-deoxyguanosine 
(dGuo) for 7 days. Treatment with dGuo selectively eliminates both thymocytes and 
interdigitating cells/dendritic cells (IDC/DC) from the thymic cultured tissue297. Purified 
NB ELC, and thymic DN populations as positive control (Figure S4), were added to the 
hematopoietic-depleted-lobes in culture by the hanging-drop system where they were 
cultured for 12 to 15 days.  
When added to the FTOC system, thymic DN developed like they would do in vivo. 
DP and both SP can be detected with upregulation of TCRβ and CD3 (Figure 21a). Some γδ 
T cells could also be detected. In contrast, ELCs in FTOC maintained their Thyhi profile, 
down-regulated CD2 expression, and did not upregulate any TCR, CD3 or CD8 (Figure 
21b). Even though approximately 5% of cultured ELCs did express CD4 as their in vivo 
counterpart (data not shown), they did not exhibit any other aspects of late DN, DP or SP 
thymocyte phenotype (Figure 21b). 
Upon these results we can then conclude that neonatal ELCs are not T cell 
progenitors. 
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Figure 21. ELCs into FTOC system. 
a-b. Progeny of the thymic DN (a) and ELCs (b) in fetal thymic organ culture for 12 to 15 days were analyzed 
by flow cytometry. T cell lineage markers such as CD4, CD8 and CD2 were used in this analysis, as well as 
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4.9 Neonatal ELCs express Natural Killer markers 
As described before, CD2 and Thy1 are not restricted to the T cell lineage, since they 
can also be found in the surface of NK cells. Therefore, and since ELCs failed to further 
develop into T cells in in vitro and ex vivo culture systems, we hypothesized that the ELC 
population might belong to the NK-like family. 
Murine NK cells are characterized by specific markers on their surface such as NK1.1 
and CD49b. Therefore, we phenotyped the ELC population for these markers, as well as 
others linked to the NK family. Both WT and Rag1-/- ELC populations expressed low levels 
of CD49b and had a partial expression of NK1.1 (Figure 22a and b).  
Interleukin 2 (IL-2) is a major growth factor for mature NK cells298,299. Freshly isolated 
NK cells preferentially express IL-2Rβ, through which IL-2 plays a pivotal role in 
proliferation and induction of cytolytic activity300. Thus, we investigated the expression of 
IL-2Rβ in the NB populations of WT and Rag1-/- animal models and found that both 
expressed low levels of such receptor (Figure 22a and b). 
The CD2/SLAM family includes several members such as CD2, 2B4 (CD244) and CD48. 
Murine CD244 is expressed on different subsets of cells, such as  T cells, mast cells, 
αβ T cells, and all NK cells301–303. In addition, CD48 is expressed widely on hematopoietic 
cells including T and NK cells and has been identified as a ligand for CD244 and CD2304. By 
analyzing the expression of both CD244 and CD48, we found that ELCs in both models 
expressed high levels of these molecules (Figure 22a and b). Of note that CD244 and CD48 
expression was been reported to be expressed by DETCs302 and LCs305 respectively. While 
analyzing the NB epidermis we also observed that either DETC or LCs populations 
expressed both CD244 and CD48 (Figure S5). 
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Figure 22. ELCs express NK markers.  
a. Representative histograms of the level of expression of NK-like markers in the ELC population from 
epidermal cell suspensions of NB from both WT and Rag1
-/-
 models. b. Mean Fluorescence Intensity (MFI) 
representation with standard deviation (SD) bars of the intensity of the NK-like markers in the ELC 
population from both WT and Rag1
-/-











1 0 0 0

















































































1 0 0 0
2 0 0 0
3 0 0 0
4 0 0 0






















5 0 0 0
1 0 0 0 0















70 |      
4.10 Neonatal ELCs produce IFN-γ and IL-2 
In order to search for other molecular cues that relate ELCs to the NK lineage we 
purified this population from WT NB mice and proceeded with NanoString analysis. 
NanoString is a multiplexed target profiling of up to 800 transcripts in a single reaction. In 
this experimental design, cells were analyzed for their level of expression for 179 genes 
known to be differentially expressed during inflammation (Table 1). These represent a 
broad range of relevant pathways such as apoptosis, interleukin signalling, Toll-like 
receptor signalling and others. 
NanoString data was split into different categories according to their function. 
Expression of transmembrane receptors, transcription regulators, growth factors and 
G-protein coupled receptors are depicted in Figure S6, while expression of kinases, 
enzymes, and others are represented in Figure S7. Interestingly, the ELC population 
exhibited high expression for IL-18Rα, another molecule that is highly related to the NK 
lineage. Priming of NK cells by IL-18 is crucial for these cells to display full effector 
activity306. In addition, the transcription factors Fos and Jun revealed to be highly 
expressed by neonatal ELCs. Notably, in NK cells, IL-2 differentially regulates the 
expression of several transcription factors, including Jun and Fos307. 
In addition, we decided to validate at the protein level their cytokine profile since the 
NanoString data revealed that neonatal ELCs had high expression of IFN-γ, IL-13, IL-2 and 
TNF-α (Figure 23a). Hence, we proceeded with intracellular labeling of these cytokines in 
the ELC population under non-stimulated and stimulated conditions with PMA and 
ionomycin (Figure 23a and d). Under unstimulated conditions, ELCs from both WT and 
Rag1-/- NB expressed hardly any cytokine (Figure 23b and d). In contrast, upon stimulation 
ELCs from both mouse models expressed around 20% of IL-2 and IFN-γ, yet no IL-13 or 
TNF-α was detected (Figure 23c and e). IL-2 and IFN-γ production corroborates the 
hypothesis of these cells being part of an NK-like population. 
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Figure 23. Cytokine production profile of neonatal ELCs.  
a. Cytokine profile of expression by NanoString analysis of purified ELCs from NB WT. b-e. Representative 
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4.11 Neonatal ELCs are Runx3 and Nfil3 dependent 
Another possible approach to clarify the nature of this population is by their 
transcription factor dependency profile. Unfortunately, the NanoString cartridge selected 
did not have the typical NK-related transcription factors. So in order to further investigate 
this, we took advantage of different deficient mouse models for specific transcription 
factors. 
The transcription factor Runx3 is known to be expressed in NK cells, and recently has 
been shown to regulate their activation through IL-15308. Since Runx3-/- mice have an 
embryonic lethal phenotype, dying at E19 to E20, therefore we did the analysis at the 
E17.5 stage. Embryonic ELCs are dependent on the transcription factor Runx3 since 
deficient embryos had a significant reduction in their population when compared to the 
WT at E17.5 (Figure 24a-b).  
 
 
Figure 24. ELCs are dependent on Runx3.  
a. Representative dot plots of ELC population in both WT and Runx3
-/-
 E17.5 embryos analyzed by flow 
cytometry are shown. b. Dot plot identifies the absolute numbers between both mouse models. Each data 
point represents an individual embryo. Data were obtained from n=14 (WT) and n=9 (Runx3
-/-
) embryos 
from 3 independent experiments. 
 
In addition to the Runx3-deficient model, newborn epidermis from other deficient 
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RORγt (RAR-related orphan receptor gamma, encoded by Rorc) has been highly 
involved in the development of innate lymphoid populations, more specifically ILC3175. 
When analyzing the ELC population in NB from Rorc-/- we noticed that this population is 
slightly expanded in this model when compared to the WT (Figure 25a-b).  
Nfil3 (Nuclear factor interleukin-3, also known as E4-binding protein 4 (E4BP4)) has 
shown to be required for the development of all innate lymphoid cell subsets156. In 
particular for NK development, Nfil3 has shown to be crucial at driving their development 
and maturation in vivo309,310. Therefore Nfil3-/- mice exhibit a specific disruption in NK cell 
development resulting in severely reduced numbers of mature NK cells in the 
periphery310.  Nfil3-/- mice were analyzed by flow cytometry at birth. Nfil3-deficient pups 
had a significantly reduced population of ELCs when compared to the WT (Figure 25c). 
T-bet (T-box transcription factor, encoded by Tbx21) is another transcription factor 
that has been highly involved in NK cell development and maturation. Together with 
Eomes, T-bet has been shown to instruct the development of distinct NK lineages and 
control key checkpoints of their maturation171,206. However, when analyzing NB from 
Tbx21-/-, we saw no distinct phenotype from the WT since both models had similar levels 
of ELCs in their epidermis (Figure 25d). 
Altogether these results shed some light into the transcriptomic requirements of this 
specific population. ELCs are independent of RORγt and T-bet but dependent of Runx3 
and Nfil3. Yet, the exact mechanism behind this dependency remains unknown. 
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Figure 25. ELCs are independent of RORγt and T-bet but dependent on Nfil3.  
a. Flow cytometry of the ELC population in NB from both WT and Rorc
-/-
. b. Dot plot identifies the absolute 
numbers between both mouse models. Each data point represents an individual embryo. Data were 
obtained from n=6 (WT) and n=8 (Rorc
-/-
) embryos from 2 independent experiments. c. Dot plot identifies 
the absolute numbers between WT (n=11) and Nfil3
-/-
 (n=10) from 3 independent experiments d. Dot plot 
shows the absolute numbers between WT (n=9) and Tbx21
-/-
 (n=7) from 2 independent experiments. 
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5. Discussion 
Cutaneous lymphoid populations have been extensively studied under both steady 
state and inflammatory conditions. DETCs are the major lymphoid cell type in the murine 
epidermis in the steady state56, while following inflammation epidermal CD8+ T cells 
become part of the immune pool found in this tissue55. In contrast, the dermis is 
populated by different types of T cells, including αβ and γδ T cells, NK cells and the 
recently-described ILC21,50,66.  
Here we add to the knowledge of the epidermal immune compartment by 
characterizing a new lymphoid population that is present at low frequencies in the adult 
WT epidermis, but accumulates in the epidermis of adult Rag-deficient models or athymic 
mice. However, this population has shown to be heterogeneous, being ICOS+ or CD2+. 
While ICOS+ fraction are the ILC2 reported by Roediger et al, the  CD2+ fraction is our 
population of interest and named ELCs (Epidermal Lymphoid Cells). 
Interestingly, the ELC population shares some molecular cues with DETCs by being 
IL2γ and IL15Rα dependent. In human skin, the primary cellular source of IL-15 is 
keratinocytes, constitutively expressing mRNA and producing the protein in response to 
exogenous stimuli311–313. In addition, in mice,  IL-15 has been shown to promote the 
growth of DETCs by a mechanism involving the beta and gamma c-chains of the IL-2 
receptor273. Thus, interaction with keratinocytes might be in place to support the 
development and/or survival of ELCs in an IL15 dependent manner. We also hypothesize 
that DETCs and ELCs might compete for IL-15 signalling, resulting in the low frequencies 
of ELCs found in the adult epidermis. 
Furthermore, the ELC population also has similar homeostasis as DETCs and 
different from the ILC compartment, since these cells have shown to be radioresistant. 
Also, upon parabiosis, the ELCs have shown to be independent from circulating 
progenitors, similarly to DETCs. These homeostatic cues raise the possibility that ELCs, like 
DETCs314, might be restricted to an embryonic wave of progenitors that seeds the 
epidermis for life. 
Extrathymic education has been a much debated topic where several studies have 
been published showing that maturation of T cells outside the thymus can occur315,316, 
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especially since athymic mice have T cells128. Since this lymphoid population was 
expanded in the Rag1-/- and nude epidermis, plus exhibited characteristics restricted to 
the T cell-lineage, we hypothesize that the ELC population could be a pool of T cell 
progenitors in the adult mouse. It has been reported that cells belonging to T cell-lineage 
would express CD3 intracellularly281–283, and variable proportions of the ELC population 
were positive for cytoplasmic CD3. In addition, the expression of pTα is also exquisitely T 
lineage-specific and occurs in pro-T cells outside the thymus as well as at sites that 
support extrathymic T cell development285. Unexpectedly, we could also observe some 
expression of pTα in the ELC population. Both these characteristics in this population are 
in accordance with our T cell progenitor premise. Therefore, we hypothesized that either 
this lymphoid population is a pool of T cell progenitors on their way along the T cell 
differentiation pathway or is a heterogeneous pool of cells with a fraction of T cell 
progenitors together with other unknown cell types. 
It is quite puzzling that these cells exhibit a thymic DN stage-like phenotype and do 
not develop further with age. We questioned whether the presence of DETCs, by cytokine 
competition or niche occupation, would be limiting the development of the ELC 
population. One possibility, due to the CD2 expression in this lymphoid  population, 
would be that these cells were CIPs as described by Dejbakhsh-Jones and collaborators133. 
In concordance with this hypothesis is the fact that  a small population of Thy1highCD2+ 
cells, similar to CIPs found in WT, have been shown to exist in the bone marrow of  nude 
mice317. If true, these intermediate progenitors should be able to develop through an 
extrathymic pathway into mature T cells; however, using a Rag-inducible mouse model 
that enabled the reinstatement of normal thymocyte development, ELCs retained their 
existing phenotype. One possible explanation is that the adult skin simply does not 
provide the correct environment for these cells to further differentiate.  
ELCs have shown to be radioresistant and independent of circulating progenitors 
suggesting that these cells colonize the epidermis earlier than adult life, similarly to 
DETCs314. When analyzing earlier time points, before and after birth, we observed that 
ELCs are present in both Rag1-/- and WT epidermis as early as E17.5 together with DETCs. 
Throughout development of the mouse, DETC frequency increases until adulthood in the 
WT epidermis, while the ELC population reaches almost undetectable levels. 
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Contrastingly, in the Rag-deficient mice ELCs keep expanding, only decreasing slightly in 
the adult mice. The reason for the decrease in frequency is currently unknown. We 
hypothesize that the disappearance of ELCs in the WT postnatal epidermis might be due 
to direct competition with DETCs for niche occupation or cytokine requirements. 
Therefore, keratinocyte-derived IL-15 arises as a possible candidate for the cytokine 
competition theory drawn between DETCs and ELCs. Nevertheless, localization data of 
the DETCs and ELCs over the NB epidermis could shed some light in this possible 
proximity and therefore competition. 
In addition, similar to the adult data, embryonic ELCs also shared a variable 
expression of pTα, however levels of expression of CD3ε in their cytoplasm were greatly 
reduced. Cytoplasmic CD3ε can be detected in thymocytes as early as E13.0 (two days 
before expression of the TCRβ chain) and it is has been reported to be detected from DN2 
to DN3. While some DN2 might be heterogeneous for its expression, by DN3 it is 
completely established282. In addition, our fate mapping model has been reported to 
show pTα expression as early as DN1248. Thus, we hypothesize that the ELCs in late 
embryogenesis are less developed than the one in the adult epidermis, being the 
embryonic population the equivalent of the DN1 stage and the adult population more 
closely related to a stage after DN3. 
Taken together, these findings contributed to our hypothesis that this population 
does seem to belong to an early stage in the T cell lineage. However, and similarly to what 
we found with the Rag-inducible model, even before birth the embryonic skin does not 
seem to provide the correct environment for the progenitors to develop. In order to 
further study the nature of these cells and understand their true potential we decided to 
purify the newborn population and proceed with in vitro and ex vivo approaches. 
Nevertheless, upon co-culture with stromal cells supplemented with cytokines the ELC 
population failed to further develop, maintaining its phenotype. 
For many years, researchers have used ex vivo approaches to analyze the potential 
of possible T cell progenitors. By depleting the hematopoietic compartment and culturing 
thymic lobes, potential progenitors can be introduced to the stromal environment. 
Without having to add any extra cytokines it is believed that this system is a less artificial 
model that reproduces more closely what happens in vivo and throughout development. 
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Therefore we decided that FTOC would be a good system where we could test the 
potential of the ELC population. Nonetheless, while thymic DN could proceed with the 
expected T cell development that can be found in the in vivo thymus, ELCs maintained the 
same phenotype throughout the culture period. Similarly to what we found in the stromal 
culture, no upregulation of mature T cell markers such as CD3 or TCR were observed. Of 
note that a fraction of CD4+ cells was detected, yet no maturation markers followed the 
CD4 acquisition, as such it is impossible for us to assume that they are T cells. 
Even though both adult and embryonic/newborn ELCs exhibit T lineage 
characteristics such as surface and intracellular markers, they were unable to develop as 
mature T cells under FTOC conditions, stromal culture or in our Rag-inducible model. 
Taking all of these results together we need to conclude that ELCs are not T cell 
progenitors. 
The true nature of ELCs remains unknown; however as lymphoid cells, this 
population could be related to the ILC family. Yet, the phenotype of the ELC population is 
different than bona fide ILC, since they lack expression of surface markers characteristic 
of the different ILC groups, such as ICOS, NKp46, ST2 and c-kit (data not shown). More 
importantly, ELCs are radioresistant, unlike the ILC2 described by Roediger50 and other 
ILCs157,176. However, we cannot exclude that ELCs could represent a unique and 
unreported new population of ILCs with unique homeostatic features that could be 
conferred by the environment where they reside. Accordingly, all immune populations 
residing in the epidermis, such as DETCs and LCs, are relatively resistant to depletion by 
radiation and renew themselves locally278,279,318. 
Nevertheless, it is important to note that a combination of CD2 and Thy1 as 
lymphoid markers can be shared by other lineages other than T cells, such as NK cells. In a 
phenotyping approach of the NB population, we found that the ELCs in both WT and 
Rag1-/- exhibit expression of NK markers such as CD49b and NK1.1. Additionally, other 
members of the CD2 family, previously reported to be expressed by NKs301,319, such as 
CD244 and CD48 were also expressed by this population. The only known CD244-binding 
molecule is CD48. While CD244 has been reported to be expressed by DETCs302, CD48 has 
been reported to be expressed by LCs305. Yet, here we show that in the newborn 
epidermis both CD244 and CD48 are expressed by ELCs, DETCs and LCs. Together this 
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phenotype supports our new hypothesis of the ELCs being an NK-like population with a 
possible interaction among themselves or with the other immune sentinels present in the 
epidermis. 
Moreover, IL2Rβ had a low expression on populations from both WT and Rag1-/- 
mouse models at the NB stage. Previous studies have shown that depletion of either this 
receptor, IL-15 or IL-15Rα blocks NK development274–276. Therefore, in the future we hope 
to address the impact of IL-15 on the ELC population before or right after birth, to further 
understand their possibly dependency on this signalling pathway. 
Other than cytokine receptor profiling, cytokine production itself can also shed 
light on the nature of a cell. For example T cells and the newly discovered family of ILCs 
have been classified based on their cytokine profile180. Transcriptomic analysis by 
NanoString of the NB population highlighted several cytokines of interest that where then 
addressed experimentally under steady state and stimulatory conditions. We observed 
that under non-stimulatory conditions ELCs failed to produce any cytokine, however after 
stimulation, both WT and Rag1-/- populations exhibited production of IFN-γ and IL-2. This 
cytokine profile fits with the NK-like hypothesis since NKs are known to have a profile 
similar to Th1
320. We also hypothesize that the cytokines produced can act on an 
autocrine or paracrine mechanism in order to further activate cells and be involved in 
tolerogenic functions in the epidermis. 
In addition, another way to classify different cell types is through their expression 
profile and/or developmental dependency of transcription factors. By analyzing late 
embryogenesis or newborn time points of deficient mouse models, we observed that the 
ELC population is dependent on Runx3 and Nfil3. Both transcription factors have been 
reported in the literature to be highly involved in development and maturation of NK 
cells308–310; however none of them is specific to this lineage. In the future we hope to 
complement our studies by addressing the EOMES expression to further strengthen our 
hypothesis of ELCs being an NK-like population. 
In conclusion, we are still not sure about the true nature of these cells and their 
functions. However we do know that they belong to the lymphoid lineage and they are 
neither T cells or T cell progenitors, nor the ILC2 found previously in the skin by others. 
We speculate that due to the phenotype and time frame where these cells appear in 
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higher frequencies in the WT epidermis they might be involved in interactions with the 
other immune and non-immune cells in the epidermis. We hypothesize that both DETCs 
and ELCs compete for the IL-15 produced by keratinocytes, making them competitors for 
the same niche. In addition, we also dare to contemplate the hypothesis of a potential 
cooperative role of ELCs alongside LCs and DETCs in supporting the establishment of a 
mature epidermal immune system at birth. Of note that skin-resident DCs have recently 
been shown to have an active role in remodeling the skin microbiome321. Therefore, we 
hypothesize that these three immune compartments might work together on a 
tolerogenic role towards skin microbiota upon birth and during the first days of life.  A 
possible signalling pathway involved in this function could be through CD244/CD48 
expressed by ELCs, LCs and DETCS, but additional investigations would be required in 
order to further understand the mechanisms behind such hypothetical partnership. Plus, 
even though the latest phenotype characterization, as well as molecular and 
trancriptomic cues, point towards an NK-like population, more experimental approaches 
would have to be addressed in order finally understand the nature and function of this 
newly discovered population.  
The roles and lineage relations of the ELC population remain an enigma at this stage, 
and should prove a productive avenue for future research into immunity in the skin. 
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Figure 26. Suggested scheme of interaction of ELCs in the epidermis. 
IL-15 produced by keratinocytes interacts with the IL-15Rα, expressed by DETCs and possibly expressed by 
ELCs, resulting in the proliferation and possible competition between the two populations. Since CD244 and 
its ligand CD48 are highly expressed by DETCs, ELCs and LCs we propose the above mechanism of 
interaction. ELCs could interact with all of these cell types leading to their activation and cytokine 
production. This activation state could have a role in tolerance upon colonization of the newborn epidermis 
by its microbiome.  
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 population in the dermis. 
Flow cytometry of 8wo mouse dermal cell suspension. Gating strategy and histograms to identify ICOS 
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Figure S2. Generation of Rosa26-Rag mouse strain. 
a. Strategy for generation of Rosa26-Rag mouse strain by a “knock-in” insertion of Rag2-2A-Rag1 cDNA 
fragment into the Rosa26 locus. Structures of the WT Rosa26 locus, the targeting vector, and Rosa26-Rag 
locus were shown. b. Analyses of Rag activity by in vitro recombination assay. PCR assay was performed 
using feeder cells of the indicated genotype, which were transfected with pJH200 recombination template 
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Flow cytometry of brain, liver, gut, spleen, pancreas, lung, blood, thymus, dermis and epidermis of WT NB 
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Figure S4. Sort strategy for FTOC system. 
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Figure S5. Neonatal DETCs and LCs express CD244 and CD48.  
Representative plots of flow cytometry analysis of epidermal cell suspensions from of WT and Rag1
-/-
 mice. 
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Figure S6. NanoString data set A. 
NanoString data on transmembrane receptors (a), transcription regulators (b), growth factors (c) and 
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Figure S7. NanoString data set B. 
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Ccl11 Cdc42 C3ar1 Pdgfa Limk1 C1qa Creb1 Cd4
Ccl17 Cfb Ccr1 Tgfb1 Map2k1 C1qb Atf2 Cd40
Ccl19 Cfd Ccr2 Tgfb2 Map2k4 C1r Bcl6 H2-Ea
Ccl2 Gnaq Ccr3 Tgfb3 Map2k6 C1s Cebpb H2-Eb1
Ccl21b Gnas Ccr4 Map3k1 C2 Daxx Il10rb
Ccl22 Gnb1 Ccr7 Map3k5 C3 Ddit3 Il18rap
Ccl24 Gngt1 Cxcr4 Map3k7 C4a Elk1 Il1r1
Ccl3 Masp1 Map3k9 C6 Fos Il1rap
Ccl4 Masp2 Mapk1 C7 Hdac4 Il22ra2
Ccl5 Nos2 Mapk14 C8a Hmgn1 Il23r
Ccl7 Pla2g4a Mapk3 C8b Jun Il6ra
Cd40lg Plcb1 Mapk8 C9 Keap1 Il8ra
Csf1 Rac1 Mapkapk2Ccl8 Maff Il8rb
Csf2 Rhoa Mapkapk5Cd55 Mafg Itgb2
Csf3 Traf2 Mknk1 Cfl1 Mafk Ly96
Cxcl1 Pik3c2g Crp Max Tlr1
Cxcl10 Prkca Fxyd2 Mef2a Tlr2
Cxcl2 Prkcb1 Grb2 Mef2b Tlr3
Cxcl3 Ptk2 Hras1 Mef2c Tlr4
Cxcl5 Raf1 Hspb1 Mef2d Tlr5
Cxcl9 Ripk1 Hspb2 Myc Tlr6
Fasl Ripk2 Kng1 Nfatc3 Tlr7
Hc Rock2 Mbl2 Nfe2l2
Ifna1 Rps6ka5 Myd88 Nfkb1
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